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1. Introduction 3
1. INTRODUCTION 
Bee venom from Apis melifera is toxic substance, composed of only a few 
pharmacologically and enzymatically active components, such as phospholipase A, 
hyaluronidase, histamine, melittin and apamin, a mast cell degranulating (MCD) peptide 
(1).  
Knowledge of its composition and mechanism of action has been not been established until 
1940-1950s due to lack of proper methods of analysis. Thus, all effects of the bee venom 
had been attributed to its phopsholipase activity. Development of different techniques, such 
as electrophoresis, chromatography, gel-filtration, combined with pharmacological and 
biochemical analysis allowed to fully identify the active components of bee venom.  
Melittin is the major toxic component of the venom and it constitutes 50% of dry venom. It 
was identified in 1952 during the electrophoretic experiment with phospholipase A. 
Melittin is released from its precursor, promelittin, during its synthesis in the bee, and will 
be formylated at a later stage. It is a 26 amino acid residue long cationic peptide with 
hemolytic activity and a broad antimicrobial spectrum due to its ability to disrupt cell 
membranes (1, 2). 
Melittin not only interacts with lipid membranes (described in more details in Chapter 1.2), 
but also exhibits various other effects. It inhibits transport pumps, such as (H+ + K+) 
ATPase (3) and (Na+ + K+) ATPase (4) and increases the permeability of cell membranes 
to ions. It induces inhibition and aggregation of membrane proteins (5-8), it stimulates 
activity of phospholipase A2 (9) (cf. Chapter 1.3). 
Melittin-lipid membrane interactions were studied extensively in order to determine the 
nature of this interaction, but even up to now, the molecular mechanism of action of 
melittin is not completely established. Much of the evidence indicates that different 
mechanisms are responsible for the different effects of the peptide (10).  
1. Introduction 4 
In the present work we focused on an alternative action mechanism of melittin. As 
melittin carries a net positive charge and as negatively charged sulfate carrying 
glycosaminoglycans (GAGs) are found on almost all cell surfaces, it can be expected that 
melittin binds to the anionic groups of GAGs. There exist many studies concerning 
interactions between melittin and lipid membranes, but to the best of our knowledge the 
potential involvement of GAGs in the binding of melittin to cell membranes has not been 
explored yet. 
 
 
1.1 Melittin – Structure and Conformation 
Melittin is composed of 26 amino acid residues with the sequence shown in Figure 1.  
 
G I G V K V L T G LA PL T A L I S W I K R K R Q Q
5 10 15 20 25
 
Figure 1. Amino acid sequence of melittin in one letter code. Hydrophobic residues are presented in white, 
polar residues in grey and positively charged residues in red circles. 
 
 
It is a cationic peptide with an amino terminus composed predominantly of hydrophobic 
amino acids (residues 1-20), and a carboxyl-terminal end composed of mostly hydrophilic 
amino acids (residues 21-26). The peptide has a net positive charge of z = 5 due to 
presence of three lysines and two arginines. Four of them form a cluster, -KRKR-, at the 
carboxy terminus. The K-7 is embedded in the hydrophobic N-terminal region of the 
peptide. The asymmetric distribution of non-polar and polar amino acids leads to an 
amphiphatic structure of melittin when it adopts α helical conformation. A crystal structure 
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of melittin in aqueous solution was determined by X-ray analysis at high-resolution of 2 Å 
(11) (Figure 2A). Each melittin molecule is composed of two α-helical segments with a 
bent due to presence of proline at position 14, therefore the overall shape is called “a bent 
rod”.  
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Figure 2. (A) Crystal structure of melittin α-helix determined by Terwilliger and Eisenberg (from PDB, entry 
2MLT). (B) Helical wheel diagram of melittin; positively charged and polar amino acids are marked in red 
and grey, respectively. 
 
 
Although melittin contains a high proportion of hydrophobic amino acids, it is highly 
soluble in water and moderately soluble in methanol. Melittin is very sensitive to the 
solution conditions and can adopt different conformations and aggregation states in 
aqueous solution. It is largely unstructured in water, but forms an α-helix upon binding to 
lipid membranes (12). At low peptide concentration and low ionic strength melittin occurs 
mostly as a monomer with essentially random coil conformation. When the peptide 
concentration and/or the salt concentration are increased, melittin aggregates into a 
tetramer with a high content of α-helix structure (13-15). 
The pH of the aqueous solution also influences the conformational states of the peptide. A 
change of the conformation of melittin towards a tetramer at high pH was observed, 
A B 
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although the concentration of the peptide and the ionic strength of the solution were kept at 
low level (16).  
All these studies show that the self association/aggregation of the peptide is a complex 
process and depends on the peptide concentration and the solution properties such as ionic 
strength and pH. 
 
 
1.2 Melittin - Lipid Membranes Interaction 
The interaction of melittin with lipid membranes has been investigated extensively, both 
experimentally and theoretically (17-23). The various studies show that the interaction 
depends on the properties of the peptide in aqueous solution, peptide concentration, lipid 
composition, hydration level, and the membrane potential (10). The affinity of melittin is 
larger for membranes composed of negatively charged lipids than for zwitterionic lipids. 
The partition constant of melittin into the membranes composed of POPC/POPG 
(80mol/20mol) is Kp = 4.5 x 104 M-1 (18), whereas a 20-fold smaller partition constant of 
Kp = 2.1 x 103 M-1 was found for pure POPC (21). This indicates that hydrophobic as well 
as electrostatic interactions are involved in the binding of melittin to membranes (18, 24). 
Two different mechanisms have been proposed for the hemolytic activity of melittin. In 
one model melittin acts on the lipid membrane through pore formation. The peptides can 
insert into the hydrophobic core of the membrane, so the binding to the membrane is 
predominantly driven by hydrophobic interactions. Some studies envisage a barrel-stave 
mechanism (25-27); others suggest the formation of toroidal pores (23, 28). In barrel-stave 
model, shown schematically in Figure 3A transmembrane amphiphatic α-helices form 
bundles in which hydrophobic surfaces interact with the lipid core of the membrane, and 
the hydrophilic surfaces point inwards forming a pore. The peptide molecules with a length 
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of ~ 37 Å span a nearly flat bilayer with thickness of ~34 – 46 Å, and aggregate to line an 
aqueous channel. 
In the toroidal model, Figure 3B, the lipid layer continuously bends from the top leaflet to 
the bottom leaflet through the toroidal hole, so the pore is lined by both the lipid 
headgroups and peptide molecules. 
 
A
B
 
Figure 3. Schematic drawings of (A) ‘barrel stave pore’ and (B) ‘toroidal pore’ models. Peptide molecules are 
presented as red rectangles, and lipids are shown with dark grey circles as headgroups and wavy hydrocarbon 
chains. 
 
 
An alternative ‘detergent-like’ model, schematically shown in Figure 4, assumes that 
melittin behaves much as a detergent. At low concentrations of the peptide, the molecules 
are oriented parallel to the surface of the bilayer (Figure 4A). The peptide does not insert 
into the hydrophobic core of the membrane, but rather binds to the lipid headgroups. The 
initial interaction with negatively charged phospholipids is electrostatically driven, since 
the peptide is positively charged. Increasing the peptide concentration causes aggregation 
and a reduction of the bilayer thickness (Figure 4B). When a critical concentration is 
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reached, the peptide changes its orientation and disrupts the bilayer, inducing disintegration 
of the membrane into micelles (29-32) (Figure 4C). 
 
A
 
B
 
C
 
Figure 4. Detergent like model of melittin mode of action. (A) At low concentration the peptide molecules are 
oriented parallel to the surface of the lipid membrane; (B) increasing the peptide concentration causes 
aggregation of the peptide molecules and thinning of the membrane; (C) above the threshold concentration 
peptide molecules inserts into the membrane causing its disintegration into micelles. Peptide molecules are 
presented as red rectangles, and lipids are shown with dark grey circles as headgroups and wavy hydrocarbon 
chains. 
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A clear decision between the various models is not possible at present and the influence of 
various parameters such as the peptide-to-lipid ratio, membrane composition, temperature, 
hydration or buffer compositions needs to be considered (29). 
Cholesterol, an essential component of eukaryotic membranes, also influences on the 
activity of melittin. Tryptophan which is present in melittin could potentially form a stable 
complex with cholesterol. On the other hand the tight lipid packing induced by cholesterol, 
could reduce the binding affinity of the peptide to membranes. 
The erythrocyte membrane, which is the natural target for melittin, is rich in cholesterol. It 
was shown that cholesterol inhibits the lytic activity of melittin. The concentration of 
melittin required for 50% lysis was ~3 times lower in cholesterol-depleted erythrocytes, 
than in case of control erythrocytes. The LD50 for melittin-induced lysis in control 
erythrocytes was found to be LD50 ≈ 0.67 μM, whereas for cholesterol depleted 
erythrocytes LD50 was only 0.21 μM (33). These results are in agreement with results 
obtained with model membranes, which showed that melittin binding and melittin-induced 
leakage decrease with increasing cholesterol concentration in lipid vesicles (28, 34).  
 
 
1.3 Activity of Melittin on Cells 
Melittin belongs to the larger group of antimicrobial peptides and has broad spectrum of 
antibacterial activity. It disrupts cell membranes and kills Gram-negative and Gram-
positive bacteria in micromolar concentration range.  
Melittin is also known for its high lytic activity on the human erythrocytes (2, 35) and other 
eukaryotic cells. It rapidly binds to human red blood cells already in sub-micromolar 
concentrations, induces release of hemoglobin, an increase of membrane permeability, and 
finally lysis of the cells. An apparent dissociation constant, Kd, of 30 nM and the maximum 
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binding capacity of 1.8 x 107 molecules/cell for melittin binding to the human red blood 
cells were found (2). Melittin produces lysis of human red blood cells by a colloid osmotic 
mechanism. In this mechanism damage to the erythrocyte membrane initiates leakage of 
cations, followed by swelling of the cells and hemolysis. This mechanism is supported by 
the observation that increased permeability of ions occurs during the first few minutes after 
the cells are treated with melittin and the release of hemoglobin is secondary to the 
formation of the lesions (2, 35). 
Besides its powerful antimicrobial and lytic activity, melittin exhibits a variety of other 
biological effects. It is responsible for the non-specific inflammatory response, which is 
produced by bee venom (36). It was also reported that melittin is a weak allergen in 
humans (37-39). Melittin reduces the rotational mobility of band 3, which is a major 
protein component of the human erythrocyte (5, 6, 40). It also causes aggregation of 
membrane proteins including band 3 (5), bacteriorhodopsin (7) and the Ca+-ATPase (8, 
41). It was shown that the immobilization and aggregation of these proteins depends on the 
melittin/protein ratio, not the melittin/lipid ratio, which suggests that melittin could cause 
these effects via direct interaction with the proteins. A crosslinking of the proteins into 
larger aggregates is induced by electrostatic interaction between positively charged 
residues from C-terminus of melittin and the negatively charged residues on membrane 
proteins. 
Melittin is a potent inhibitor of the (H+ + K+) ATPase (3, 42, 43), the (Na+ + K+) ATPase 
(4) and Ca+-ATPase (8, 41). Inhibition of the functions of these proteins occurs through 
direct interaction with the protein. The (H+ + K+) ATPase contains a binding site for 
polypeptides which exhibit an amphiphatic helical motif (43). When occupied by melittin 
this leads to the inhibition of the protein function. In case of the (Na+ + K+) ATPase it was 
shown that conformational changes of the protein upon binding of melittin interfere with 
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the normal conformational changes induced by K+ and Na+, which are required for the 
function of this pump (4). 
Melittin also stimulates the activity of phospholipase A2 up to about 5-fold, while similar 
effects could not be observed in the absence of the peptide (9). Melittin can also neutralize 
the activation of bovine brain phosphodiesterases by calmodulin via complex formation 
with calmodulin in the presence of Ca2+ (44). 
The net positive charge and the ability to disrupt lipid membranes make melittin to an ideal 
candidate as a gene delivery vector. However, because melittin is showing high hemolytic 
activity, its therapeutic applications are mainly dependent on the development of non-
hemolytic analogs. There are number of strategies to overcome the toxic effects of melittin 
and keep its therapeutic activity. Melittin and melittin analogs can be conjugated to 
polyethylenimine (PEI), a cationic polymer used in gene transfection. It was shown that 
melittin-PEI conjugates are non-hemolytic, form stable complexes with DNA and increase 
gene transfection up to 3 orders of magnitude when compared to unconjugated PEI (45, 
46). Dioleoylmelittin is the conjugate formed by covalently coupling melittin to a 
derivative of dioleoylphosphatidylethanolamine (DOPE). This hybrid molecule binds DNA 
and form complexes that transfect with a high level of gene expression (47). 
This enhanced gene transfer in case of melittin conjugates correlates with an improved 
endosomal release is connected with ability of melittin to disrupt membrane and thereby 
facilitate DNA release into the cytoplasm (45, 48). 
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1.4 Magainin 2 and Nisin Z - Two other Representatives of 
Antimicrobial Peptides Family 
Antimicrobial peptides are large group of the peptides which share several properties. They 
consist of 12 to 50 amino acid residues, they have a net positive charge, a large proportion 
of hydrophobic residues and the ability to associate with and disrupt lipid membranes. 
Magainin 2 and nisin Z are two specific examples which belong to this group. 
Magainin 2 is secreted from the skin of the african clawed frog, Xenopus leavis. It consists 
of 23 amino acid residues with a primary structure shown in Figure 5, and has a net 
positive charge of z = 4.  
 
G I G F H S A K F GK KL K A F V G E I M N S
5 10 15 20
 
Figure 5. Amino acid sequence of magainin 2 in one letter code. Hydrophobic residues are presented in white, 
polar residues in grey, positively charged residues in red. 
 
 
Similar to melittin, magainin 2 has a random coil conformation in aqueous solution, but 
assumes an α-helical conformation in the presence of lipid membranes. Magainin 2 helix is 
amphiphatic, but, in contrast to melittin, hydrophobic and polar amino acid side chains are 
separated on opposite faces of the helix (49, 50).  
Binding of magainin 2 to lipid membranes causes membrane destabilization and pore 
formation. The action mechanisms of magainin 2 on the lipid membranes include torroidal 
pore formation. Magainin 2 has a high affinity for negatively charged lipids and this 
affinity decreases with decreasing content of negatively charged lipids (51, 52). 
Magainin 2 is known for its antimicrobial activity by permeabilizing the bacterial 
membrane. In contrast to melittin, magainin 2 does not cause lysis of the eukaryotic cells at 
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its effective antimicrobial concentrations. For example, the IC90 of melittin for its 
antimicrobial activity towards E.Coli is ~ 5 μM which is comparable to the concentration 
required to induce hemolysis in the eukaryotic cells (2, 53). For magainin 2, the IC90 value 
against E.Coli bacteria is ~ 19 μM (53), but the hemolysis is not detected up to 150 μg/ml 
(50). Recent studies show that magainin 2 is not toxic on red blood cells even up to 400 
μg/ml (53). 
Nisin Z is a 34 residue peptide produced by the lactic bacteria Lactoccocus lactis with 
sequence shown in Figure 6. Because it is not toxic for humans and has high a activity 
against Gram-positive bacteria, it finds applications as a food preservative. 
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Figure 6. Amino acid sequence of nisin Z in one letter code. Hydrophobic residues are presented in white, 
polar residues in grey, positively charged residues in red, lanthionine residues in dark blue and dehydrated 
residues in light blue circles. Dha, dehydroalanine; Dhb, dehydrobutyrine; A-S-A, lanthionine; Abu-S-A, β-
methyllanthionine [from (54)]. 
 
 
Due to posttranslational modifications nisin Z contains several unusual dehydroresidues 
and five thioether-bridged lanthionines (54, 55). Nisin Z shares some characteristic with 
melittin and magainin 2. It has a net positive charge of z = 4 and its structure possesses 
amphiphatic properties.  
Nisin Z kills cells by pore formation in the plasma membrane (54). The first step is binding 
to the target membrane, followed by insertion into the lipids phase leading to pore 
formation. Nisin Z binds preferably to anionic lipid membranes. It was shown that increase 
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of an anionic lipid content over 40% cause significant increase in the amount of bound 
nisin Z (56).  
Compared to magainin 2 and melittin, nisin Z kills Gram-positive bacteria already in 
nanomolar range. This very high activity of nisin Z is due to high affinity of the peptide to 
Lipid II, a precursor in the bacterial cell wall synthesis. Before insertion of the peptide into 
the membrane and pore formation, nisin Z binds to Lipid II. The interaction with Lipid II, 
together with the membrane disturbing properties make nisin Z a powerful antimicrobial 
agent (54, 57).  
 
 
1.5 Glycosaminoglycans - Structure, Biosynthesis and Function 
Studies on the mechanism of action of melittin have focused almost exclusively on the 
membrane perturbing properties of this peptide, investigating in detail the melittin-lipid 
interaction. Melittin carries a net positive charge of z = 5 and it can be expected that it not 
only interacts with lipid membranes but can also bind to polyanions such as sulfate 
carrying glycosaminoglycans (GAGs) which are found on almost all cell surfaces.  
Glycosaminoglycans are highly negatively charged polysaccharides composed almost 
entirely of repeating disaccharide units. The disaccharide units contain modified sugar 
moieties, either N-actetylgalactosamine or N-acetylglucosamine, and uronic acid, such as 
glucuronate or iduronate. Attached to the protein core (either glypicans or syndecans) they 
form proteoglycans, which are found on the cell surface of the eukaryotic cells and are 
involved in cell adhesion, migration, proliferation, differentiation (58, 59). 
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Figure 7. Schematic model of proteoglycans. HS – heparan sulfate, CS – chondroitin sulfate. 
 
 
Heparan sulfate (HS) and heparin are members of GAG family. These linear 
polysaccharides vary in length from 30 to 200 disaccharides. The disaccharide unit is built 
of uronic acid-(1→4)-D-glucosamine repeating disaccharides. Heparin and HS are not 
molecules with a well-defined sequence of disaccharide units but rather a heterogeneous, 
polydisperse family of related molecules. 
The uronic acid may be present as β-D-glucuronic acid (GlcA) or as the C-5 epimer α-L-
iduronic acid (IdoA). Both of them may be 2-O-sulfated (GlcA(2S) and IdoA(2S)). The β-
D-glucosamine (GlcN) may be either N-sulfated (GlcNS) or N-acetylated (GlcNAc), both 
of them may be 6-O-sulfated (GlcNS(6S) and GlcNAc(6S)). The N-sulfated glucosamine 
may be also 3-O-sulfated (GlcNS(3S) and GlcNS(3,6S). The different patterns of the 
monosaccharide substitution give rise to a large number of complex primary sequences.  
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Figure 8. Monosaccharides building blocks for HS and heparin [from (59)]. 
 
 
HS and heparin contain the same repeating disaccharide units. The units are present in 
different proportions, so that their primary structure differs significantly from each other. 
IdoA(2S)-(1→4)-GlcNS(6S) is the most abundant disaccharide unit of heparin. The 
GlcA/IdoA and GlcNAc/GlcNS ratios are higher, but the sulfates content is lower in HS 
than in heparin. HS has a domain structure, with NA domains, heparin-like NS domains, 
and NA/NS transition segments. The NA domain is built from repeating GlcA-(1→4)-
GlcNAc disaccharides and this domain is not sulfated. Highly sulfated NS domains are the 
IdoA-(1→4)-GlcNS disaccharides units. These two domains are separated by segments 
consist of GlcNAc- and GlcNS-containing disaccharides. Also common for HS is the 
observation that all chains contain approximately equal concentrations of acetylated and 
sulfated disaccharides (59-61). 
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NMR spectroscopy and molecular modeling methods (62-65) are often employed to 
determine the three-dimensional structure of heparin and HS. The overall conformation is 
mainly determined by torsion angles of the glycosidic bonds that link the monosaccharides 
and the conformation of the monosaccharides. It was shown that the pyranose rings of 
GlcA and GlcN are in the rigid 4C1 chair conformation. The pyranose ring of IdoA is more 
flexible, having the ability to adopt multiply low-energy conformations such as 1C4, 4C1, 
2S0, 0C2 (66, 67). Heparin and HS do not fold into structures resembling the tertiary 
structure of proteins, but they adopt structures that have spatially defined patterns of 
anionic groups for the interaction with proteins (68, 69). 
HS and heparin are synthesized as HS/heparin proteoglycans. The polysaccharide chain is 
synthesized as non-sulfated precursor by sequential addition of GlcNAc and GlcA to a core 
protein primed by a tetrasacchride acceptor attached through xylose to specific serine 
residues. Transformation of the synthesized polymer chains starts with replacement of the 
acetyl groups of GlcNAc monosaccharides with sulfate groups. This deacetylation and 
sulfation is initiated at random sites on the polymer chains, and then continues along the 
chain. The modification also involves conversion of GlcA into IdoA and sulfation at 
various sites. In heparin, modification of the polymer chains are far more extensive than in 
HS and heparin lacks both the distinctive domain structure of HS (NA/NS transition 
segment) and the core acetylated sequence (NA domain). The number of O-sulfated groups 
is more variable in HS than in heparin, in the range of 0.2-0.7 O-sulfates per disaccharide, 
whereas for heparin an average is 2.4 O-sulfates per disaccharide. 
The synthesis of HS and heparin is regulated by set of enzymes, including transferases, 
sulfotransferases and epimerases, which are arrayed in the Golgi apparatus (58). Upon 
conclusion of the synthesis and the modifications membrane associated HS/heparin 
proteoglycans are rapidly transferred to the cell surface or extracellular matrix (70). The 
scheme of HS biosynthesis is shown in Figure 9. 
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Figure 9. Scheme of HS chain biosynthesis. Xyl-xylose; Gal-galactose; GlcA-glucuronic acid; GlcNAc-N-
acetylated glucosamine; IdoA-iduronic acid. Regions that have been implicated in binding of specific lignads, 
such as FGF-1/FGF-2 and antithrombin are show. Taken from (58). 
 
 
HS is expressed and secreted by most of the mammalian cells. HS is located on the cell 
surface and in the extracellular matrix. It has a wide range of activities and functions, 
including cell adhesion (71), regulation of cellular growth and proliferation, developmental 
processes (72), and blood coagulation (73). HS interacts with basic fibroblast growth factor 
(bFGF), other proteins from this family and their receptor tyrosine kinase (74), 
transforming growth factors (TGFs), bone morphogenetic proteins (BMPs) (75), 
chemokines, interleukins, enzymes and enzymes inhibitors, lipases and apolipoproteins 
(76, 77), plasma proteins and others (78, 79). It is involved in the internalization of viruses 
(80, 81), basic peptides and polycation-nucleic acid complexes (82), as well as in 
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angiogenesis (83) and tumor metastasis (84). All of these processes involve interaction 
between HS and proteins. 
Heparin is found only in the secretory granules of mast cells and is released during the 
inflammatory degranulation reactions (85, 86). Heparin is mainly used clinically as an 
anticoagulant. It was shown that it binds hundreds of proteins. Since it is found only in 
secretory granules of mast cells, its physiological significance has been questioned. 
However, there is increasing interest in the characterization of the interaction of heparin 
with proteins, because of its potential use in therapy, e.g. as modulation of angiogenesis 
(87), tumor metastasis(88) and viral invasion (89, 90). Also, binding of heparin to proteins 
can be used as a model for the interaction of highly sulfated domains of HS chains with 
different proteins and peptides. 
 
 
1.6 Interaction of HS and Heparin with Proteins and Peptides 
HS and heparin interact with a large variety of different proteins. These interactions are 
primarily driven by electrostatic interactions and they involve interactions between anionic 
groups of the polysaccharides with positively charged residues of the proteins and peptides. 
HS and heparin have highly negative charge densities and they behave as polyelectrolytes 
in solution. According to polyelectrolyte theory, considerable fraction of these highly 
charged poly-anions is neutralized by Na+ due to counterion condensation (91). Upon 
binding of the peptides and proteins with HS, there is a release of Na+ counterions from the 
polysaccharides. The binding reactions between HS and proteins are ion exchange 
processes with the cationic residues of the bound peptides and proteins serving as 
counterions. 
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It was shown that HS/heparin interact electrostatically with short charged peptides, BNP 
(92), HIP peptide (93), bFGF (94), LPL (95). The dissociation constants, Kd, range from 
0.3 nM (LPL) over 0.5 μM (bFGF) to 43 μM (HIP). Salt dependence studies confirm that 
electrostatic interactions are involved in the binding process. The binding affinity decreases 
with increasing salt concentration as predicted by polyelectrolyte theory. The ionic 
contribution to the binding process can be calculated (91, 96). In all cases it was however 
shown that the binding interactions are not purely electrostatic, but they comprised also a 
nonionic component. 
The spatial arrangement of the positive charged residues also plays a role in binding of the 
peptides and proteins to HS/heparin. In the case of HIP peptide, the all D-peptide with the 
same sequence binds equally well and is equally effective, while the peptide with 
scrambled HIP peptide sequence had no effect. 
It was also shown in model experiments that that lysine binds distinctly less to heparin that 
does arginine (97). Similar results were obtained for the interaction with HS (98). 
Likewise, histidine does not contribute significantly to the binding of the peptides to HS. 
This suggests that arginines could promote a tighter interaction with glycosaminoglycans 
than lysine and histidine (97, 98). 
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2. AIM OF RESEARCH 
Melittin is a short cationic peptide with cytolytic and antimicrobial properties. Studies 
on the action mechanism of melittin have focused almost exclusively on the membrane 
perturbing properties of this peptide, investigating in detail the melittin-lipid interaction. 
Although extensive of studies the molecular mechanism of action of melittin is not 
completely established.  
In the present work we focused on an alternative mechanism of action of melittin on 
the cell membranes. As melittin carries a net positive charge of z = 5 it can be expected that 
it not only interacts with lipid membranes but can also bind to polyanions such as sulphate 
carrying glycosaminoglycans (GAGs) which are found on almost all cell surfaces. The 
melittin-GAG interaction could initiate cell lysis enhancing the melittin-lipid interaction.  
The first step of this work was to investigate if melittin exhibits any affinity to GAGs. 
We used high-sensitivity isothermal titration calorimetry (ITC) to obtain a complete 
thermodynamic characterization of melittin binding to three different GAGs, namely 
heparan sulfate, heparin and dermatan sulfate. The structural changes of melittin induced 
by binding to these polyanions were followed by circular dichroism (CD) spectroscopy. In 
addition, right-angle static light-scattering and dynamic light-scattering were employed, to 
gain information about size and the polydispersity of aggregates/complexes which are 
formed upon melittin-HS interaction. We wanted also to compare the specificity of melittin 
binding to GAGs to analogous measurements with magainin 2 and nisin Z, two 
amphiphatic and antimicrobial peptides with similar lipid binding properties as melittin. 
Magainin 2 is known of its antimicrobial properties, but in contrast to melittin does not 
cause lysis of eukaryotic cells. Nisin Z shows activity against various Gram-positive 
bacteria. With this study we wanted to answer the question if the interaction with GAGs is 
general property of antimicrobial peptides or is just unique for melittin. 
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Once the thermodynamic data of the melittin-GAG equilibrium were established, it 
was interesting to investigate the cytotoxic effect of melittin on cells, which lack GAGs on 
the surface. For this purpose a pgsA-745 cell line defective in the biosynthesis of GAGs 
was used. PgsA-745 cells are deficient in xylosyltransferase, the enzyme responsible for 
the initiation of chondroitin sulfate and heparan sulfate biosynthesis in vivo. This mutant 
cell line does not produce GAGs. As a control CHO K1 (Chinese hamster ovary cells), a 
corresponding wild-type cell line, was employed. 
In the last part of this work, we describe the interaction of retro-inverso 
dioleoylmelittin (riDOM) with HS. RiDOM is a hybrid molecule, obtained by covalently 
coupling of retro-inverso analog of melittin to a lipid moiety, to form a stable and efficient 
gene transfer system, which shows no haemolytic activity. The net positive charge of this 
conjugate, suggest that similarly to other cationic lipids and cell-penetrating peptides, the 
cellular uptake is mediated by GAGs. Again we used ITC to characterize the 
thermodynamic equilibrium between riDOM and HS and CD spectroscopy to follow the 
conformational changes upon binding of riDOM to HS. Dynamic light-scattering 
measurement provided the information about size and polydispersity of the 
aggregates/complexes. 
Furthermore, we use ITC to describe binding of melittin to large unilamellar lipid 
vesicles as there are yet only few thermodynamic parameters of the interaction between 
melittin and lipid vesicles. 
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ABSTRACT 
Melittin is a 26-residue cationic peptide with cytolytic and antimicrobial properties. Studies 
on the action mechanism of melittin have focused almost exclusively on the membrane 
perturbing properties of this peptide, investigating in detail the melittin-lipid interaction. 
Here we report physical-chemical studies on an alternative mechanism by which melittin 
could interact with the cell membrane. As the outer surface of many cells is decorated with 
anionic (sulfated) glycosaminoglycans (GAGs), a strong coulombic interaction between the 
two oppositely charged molecules can be envisaged. Indeed, the present study using 
isothermal titration calorimetry reveals a high affinity of melittin for several GAGs, i.e. 
heparan sulfate (HS), dermatan sulfate, and heparin. The microscopic binding constant of 
melittin for HS is 2.4 x 105 M-1, the reaction enthalpy is 0melittinHΔ = -1.50 kcal/mol  and the 
peptide-to-HS stoichiometry is ~ 11 at 10 mM Tris, 100 mM NaCl, pH 7.4 and 28 ºC. 
0
melittinHΔ  is characterized by a molar heat capacity of 0pCΔ = -227 cal mol-1 K-1. The large 
negative heat capacity change indicates that hydrophobic interactions must also be 
involved in the binding of melittin to HS. Circular dichroism spectroscopy demonstrates 
that the binding of the peptide to HS induces a conformational change to a predominantly 
α-helical structure. A model for the melittin-HS complex is presented. Melittin binding was 
compared with that of magainin 2 and nisin Z to HS. Magainin 2 is known for its 
antimicrobial properties, but does not cause lysis of the eukaryotic cells. Nisin Z shows 
activity against various Gram-positive bacteria. Isothermal titration calorimetry 
demonstrates that magainin 2 and nisin Z do not bind to HS (5-50 °C, 10 mM Tris, 100 
mM NaCl, pH 7.4). 
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Melittin is the major protein component of the bee venom of the honey bee Apis Melifera 
and has hemolytic activity and antmicrobial properties (1, 2). Melittin is composed of 26 
amino acid residues with the sequence H2N-GIGAVLKVLTTGLPALISWIKRKRQQ-
CONH2. It is a cationic peptide in which the amino-terminal end is composed 
predominantly of hydrophobic amino acids (residues 1-20), whereas the carboxyl-terminal 
end has a stretch of mostly hydrophilic amino acids (residues 21-26). This uneven 
distribution of hydrophobic and polar residues gives melittin its amphipathic properties. 
Melittin is water soluble and exhibits strong affinity to lipid membranes. It is largely 
unstructured in water, but forms an α-helix upon binding to lipid membranes (3). Melittin 
is very sensitive to the solution conditions and can adopt different conformations and 
aggregation states in aqueous solution. At low peptide concentration and low ionic strength 
melittin occurs as a monomer with a mostly random coil conformation. When the peptide 
concentration and/or the salt concentration are increased, melittin aggregates into a 
tetramer with a high content of α-helix structure (4-6). 
The interaction of melittin with the lipid membrane has been investigated extensively, both 
experimentally and theoretically (7-13). The various of studies show that the interaction 
depends on the lipid composition, the peptide concentration, the hydration level, and the 
membrane potential (14). The affinity of melittin is larger for membranes composed of 
negatively charged lipids than for zwitterionic lipids, indicating that hydrophobic as well as 
electrostatic interactions are involved in the binding of melittin to membranes (8, 15).  
Two different action mechanisms have been proposed for the hemolytic activity of melittin. 
In one model melittin acts on the lipid membrane through pore formation. Some studies 
envisage a barrel-stave mechanism (16-18), others suggest the formation of toroidal pores 
(13, 19). The alternative ‘detergent-like' model assumes that melittin behaves much as a 
detergent. At low concentrations of peptide, the molecules are oriented parallel to the 
surface of the bilayer. Increase of the peptide concentration causes aggregation and 
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reduction of the bilayer thickness. When a critical concentration is reached, the peptide 
changes its orientation and disrupts the bilayer, inducing disintegration of the membrane 
into micelles (20-23). A decision between the various models is not possible at present and 
the influence of various parameters such as the peptide-to-lipid ratio, membrane 
composition, temperature, hydration or buffer compositions, needs to be considered (23). 
As melittin carries a net positive charge of z = 5 it can be expected that it not only interacts 
with lipid membranes but can also bind to polyanions such as sulfate carrying 
glycosaminoglycans (GAGs) which are found on almost all cell surfaces. This interaction 
has not been investigated before, but related studies with two melittin analogs have 
recently been reported (24). 
In the present study we have used high-sensitivity isothermal titration calorimetry (ITC) to 
obtain a complete thermodynamic characterization of melittin binding to three different 
glycosaminoglycans, namely heparan sulfate, heparin and dermatan sulfate. In addition, the 
structural changes of melittin induced by binding to these polyanions were followed by 
circular dichroism (CD) spectroscopy. Finally, we have compared the specificity of 
melittin binding to GAGs with analogous measurements with magainin 2 and nisin Z , two 
amphiphatic and antimicrobial peptides with similar lipid binding properties as melittin. 
 
MATERIALS AND METHODS 
Materials. Melittin from bee venom was purchased from SIGMA (St. Louis, MO). 
Synthetic melittin and magainin 2 were purchased from BACHEM AG (Bubendorf BL, 
Switzerland) (purity >97% by reverse phase HPLC). The peptides were used without 
further purification. The concentration of melittin in aqueous solution was determined by 
UV spectroscopy at 280nm using absorption coefficient of 5570 M-1cm-1 (5). Nisin Z was 
kindly provided by Dr. E. Breukink from Utrecht University. Heparan sulfate (HS), sodium 
salt (from porcine intestinal mucosa, average molecular weight, 13655 Da, sulfur content 
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5.51%) and dermatan sulfate (DS), sodium salt (from porcine intestinal mucosa, average 
molecular weight, 41 400 Da, sulfur content 6.85%) were from Celsus Laboratories 
(Cincinnati, OH). Low molecular weight heparin, sodium salt (from porcine intestinal 
mucosa, average molecular weight 3000) was from SIGMA (St. Louis, MO). All other 
chemicals were of analytical or reagent grade. Tris buffer (10mM 
tris(hydroxymethyl)aminoethane, pH 7.4) was prepared from 18MΩ water obtained from a 
NANOpure A filtration system. NaCl concentrations were variable (50 to 250 mM) and are 
specified in the legends of each figure. The samples were degassed immediately before use. 
 
Isothermal Titration Calorimetry. All measurements were made with a Microcal VP-ITC 
calorimeter (Microcal, Northampton, MA). Titrations were performed by injecting 10 μL 
aliquots of the glycosaminoglycan solution into the calorimeter cell (Vcell = 1.4037 mL) 
containing peptide at a concentration of typically 90-100 μM. The concentrations of the 
injected glycosaminoglycan solution were about 100 μM for HS, 35 μM for DS and 500 
μM for heparin.  
The heats of dilution were determined in control titrations by injecting glycosaminoglycan 
solution into pure buffer. The heats of dilution were small (~ -1 to 1 μcal), and were 
included in the final analysis. Raw data were processed using the Origin software provided 
with the instrument. The temperature was set as indicated in the legends of the figures. All 
measurements were performed in Tris buffer (10 mM, pH 7.4) with varying NaCl 
concentrations. 
 
Circular Dichroism Spectroscopy. CD measurements of melittin in the absence and the 
presence of glycosaminoglycan (buffer 10 mM Tris, 100 mM NaF, pH 7.4) were made 
using a Chirascan CD spectrometer (Applied Photophysics Ltd., Leatherhead, UK). A 
quartz cuvette with a path length of 0.1 cm was used. All spectra were corrected by 
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subtracting the buffer baseline. Results are reported as mean residue ellipticity in units of 
deg cm2 dmol-1. The percentage of peptide secondary structure was estimated from a 
computer simulation based on the reference spectra obtained by Reed and Reed (25).  
 
RESULTS  
Binding of melittin to HS. Figure 1A shows a representative calorimetric heat flow trace 
obtained by titration of synthetic melittin with HS (at 28 °C). A 91 μM solution of melittin 
was filled into the calorimeter cell (Vcell=1.4037 mL) and 10 μL aliquots of a 100 μM HS 
solution were injected at 10 minutes intervals.  The corresponding titration curve is shown 
in Figure 1B, where the reaction heats are plotted as a function of the HS / melittin molar 
ratio. The reaction heats were obtained by integration of the titrations peaks shown in 
Figure 1A and were corrected for the heats of dilution obtained in a separate HS-into-
buffer titration. 
Figure 1 demonstrates an exothermic reaction at 28 °C. The heats measured after few first 
injections are rather constant with hi ≅ -15.5 μcal per injection. As melittin is much in 
excess over HS it is reasonable to assume that all injected HS (10 nmol per injection) is 
completely bound to melittin. The molar heat of reaction of HS can thus be evaluated as 
0
HSHΔ  = -15.5 μcal/10 nmol = -15.5 kcal/mol HS. As more HS is injected the concentration 
of free melittin decreases and the heats of reaction become progressively smaller. When all 
peptide is bound to HS, the residual heats of the last few injections are due to the dilution 
of HS into buffer. The molar binding enthalpy of melittin is then determined from the total 
heat released in the titration (~170.8 μcal) and the amount of peptide in the calorimeter cell 
(127.7 nmol). For the experiment shown in Figure 1 the heat of reaction is 0melittinHΔ ≈ -1.34 
kcal/mol. The ratio 0melitin
0
HS H/H ΔΔ  = 11.5 provides the number of melittin molecules 
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bound per HS. This result can also be derived from the midpoint of the transition (Figure 
1B) at HS/mel = 0.086, the reciprocal value of which is n = 11.6.  
 
Figure 1 
 
For a complete thermodynamic characterization of the binding process including the free 
energy, ΔG0, and the entropy, ΔS0, the calorimetric data were analyzed with a multisite 
binding model, which was also used to describe the binding equilibrium of other peptides 
to HS (26, 27). In this model a long polymer such as HS is visualized as a macromolecule 
with n independent and equivalent binding sites for a ligand like melittin. The binding 
model is represented by the following equation: 
 
]P[K1
]P[nK
]HS[
]P[
t
b
+=                                                                                                                  (1) 
 
 [P] and [P]b are the concentrations of free and bound melittin, respectively, [HS]t is the 
total concentration of heparan sulfate, K is the intrinsic binding constant, and n is the 
number of melittin molecules bound per heparan sulfate polysaccharide chain. 
Because of mass conservation, the concentration of bound peptide can be described by: 
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The index t denotes the total concentration of peptide and heparan sulfate in the calorimeter 
cell after each injection step. The peptide concentration changes during the titration with 
HS because of dilution effects. 
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The concentration of bound peptide is linked to the calorimetric data by the following 
equation: 
 
V]P[HQ i,b
0
melittini δΔ=δ                                                                                                      (3) 
 
where δQi is the heat absorbed or released at the ith injection. 0melittinHΔ  is the peptide 
binding enthalpy, δ[P]b,i is the change (increase) in bound peptide concentration upon 
injection i, and V is the volume of the calorimeter cell. The solid line in Figure 1B is the 
best least-square fit to the data using eq. 1 – 3 with the following set of parameters: n = 11, 
K = 2.4 x 105 M-1, and 0melittinHΔ  = -1.50 kcal/mol (cf. Table 1). n and 0melittinHΔ  are 
consistent with simple calculations given above. In addition, the multisite binding model 
provides the binding constant, K, and, in turn, the free energy of binding, 0melittinGΔ .  
Calorimetric titrations were performed at various temperatures in the range of 5-50 °C. 
Table 1 summarizes the thermodynamic parameters derived by using the binding model 
described above. 
 
Table 1 
 
The binding stoichiometry melittin/HS varies between 9.5 to 13.5 and becomes smaller at 
higher temperatures. The reaction enthalpy shows an even stronger temperature 
dependence and changes from endothermic below 15 °C ( 0melittinHΔ  > 0) to exothermic 
above this temperature. 0melittinHΔ  decreases linearly with increasing temperature as 
demonstrated in Figure 2A . The slope of the straight line yields a molar heat capacity 
change of 0 melittin,pCΔ  = -227 cal mol-1 K-1. This result is quite different from previous HS 
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binding studies obtained with cell penetrating peptides such as TAT and R9, which reveal 
positive heat capacity values of 0 TAT,pCΔ  = 135 cal mol-1 K-1 (27) and 0 R,p 9CΔ  = 155 cal 
mol-1 K-1 (26) respectively. The negative 0pCΔ  is indicative of a hydrophobic contribution 
to the binding process, whereas the positive 0pCΔ  values are the signature for the 
electrostatic interactions (28). The solid line in Figure 2B describes the predicted 
temperature dependence of the binding constant K based on van’t Hoff’s law dlnK/dT = 
0
melittinHΔ  / RT2 taking into account the temperature dependence of the reaction enthalpy as 
ΔH(T) = ( )00p0 TTCH −Δ+Δ .  
Table 1 demonstrates that the reaction is completely entropy-driven below 15 °C as ΔH0 > 
0 but becomes mainly enthalpy-driven at 50 °C. On the other hand, the free energy of 
binding is fairly constant which is also reflected in the weak temperature dependence of the 
binding constant K (Figure 2B). A plot of ΔH0 vs. TΔS0 yields a straight line in the 
temperature interval measured (not shown). The large heat capacity change then provides 
an explanation for this enthalpy-entropy compensation phenomenon, that is, the linear 
correlation between ΔH0 and TΔS0. The temperature coefficient of ΔH0 is 0pCΔ , that of 
TΔS0 is close to 00p SC Δ+Δ . As 0pCΔ >> ΔS0 (cf. Table 1) the two thermodynamic 
parameters ΔH0 and TΔS0 vary in parallel.  
The binding constant at 28 °C is K = 2.4 x 105 M-1 and is of the same order of magnitude as 
observed for other peptide-HS equilibria measured previously (TAT, R9, mel-SH, ri-mel-
SH). This is rather unexpected since the electrostatic and hydrophobic contributions appear 
to vary quite considerably between the different peptides. 
 
Figure 2 
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We have studied the specificity of melittin binding with two further GAGs, i.e. heparin and 
dermatan sulfate (DS). Heparin is composed of the same monosaccharide building blocks 
as HS, but has higher degree of sulfation. In DS glucosamine is replaced by the 
galactosamine residue. ITC titration curves exhibit the same pattern as those observed for 
HS at identical temperatures and the binding isotherms can again be described by the 
multisite binding model of eqs 1-3. The results are shown in Table 2. 
 
Table 2 
 
For both GAGs the binding constants, K and the reaction enthalpies 0melittinHΔ  are larger 
than those obtained for HS. For heparin and DS the binding constants are of order of 106 
M-1. The peptide molar binding enthalpies, 0melittinHΔ  at 37 °C are -3.90 kcal/mol for 
heparin and -2.50 kcal/mol for DS. Likewise, the molar heat capacity changes are more 
negative with 0pCΔ  = -285.1 cal mol-1 K-1 for heparin and -241.3 cal mol-1 K-1 for DS. The 
main difference found between these glycosaminoglycans is, however, the binding 
stoichiometry. The number of binding sites for melittin at 37 °C is 2.7 for heparin, 10.4 for 
HS, and 38 for DS. However, this result is not surprising as the three polyanions have quite 
different chain lengths. A better comparison is the number of binding sites per 1kDa. With 
this normalization one finds ~ 0.76 binding sites for HS, ~ 0.90 for heparin and ~ 0.92 for 
DS per 1 kDa molecular weight.  
 
ITC studies with magainin 2 and nisin Z. Melittin belongs to a large group of amphipathic 
peptides which either disrupt the lipid bilayer in a detergent-like manner or form pores or 
related structures. The question then arises if the interaction with sulfated 
glycosaminoglycans is a general property of these microbial antibiotics. As additional 
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example we have therefore studied the binding of magainin 2 and nisin Z to HS. Magainin 
2 is secreted from the skin of the african clawed frog, Xenopus leavis. It consists of 23 
amino acid residues and has a net positive charge of z = 4. Magainin 2 is known for its 
antimicrobial properties, but in contrast to melittin does not cause lysis of the eukaryotic 
cells (29). Nisin Z, secreted by lactic bacteria Lactoccocus lactis, is a 34 amino acid 
residue peptide with also a net positive charge z = 4, with several unusual dehydro residues 
and five thioether-bridged lanthionines (30). It finds application as a food preservative and 
exerts its activity against Gram-positive bacteria. The interactions of magainin 2 and nisin 
Z with HS were studied here with isothermal titration calorimetry. We performed titrations 
of HS into magainin 2 (110-120 μM) and nisin Z (50 μM) solutions at three different 
temperatures in 10 mM Tris 100 mM NaCl, pH 7.4. The data did not reveal any binding of 
magainin 2 or nisin Z to heparan sulfate in the temperature of 5-50 °C. At least in this 
series of experiments binding to GAGs appears to be a unique property of melittin.  
 
The effect of NaCl on the interaction between HS and melittin. As ionic interactions play an 
important role in the binding of melittin to HS, we performed HS-into-melittin titrations at 
various NaCl concentrations. The thermodynamic parameters obtained at 28 °C and 
evaluated with the binding model described above are summarized in Table 3.  
 
Table 3 
 
As expected for electrostatic interactions the binding affinity of HS to melittin decreases 
with increasing salt content of the buffer. We have analyzed the salt dependence of the 
binding constant with a popular model for protein-polyelectrolyte interactions (31). HS is a 
highly charged poly-anion but a considerable fraction of its sulfate groups is probably 
neutralized by Na+ due to counterion condensation (32). Upon binding of melittin the 
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counterions are released into the bulk solution as described by the following reaction 
scheme: 
nMel)Na(HS z + V ++⋅ zNaMelHS n                 (4) 
with the corresponding equilibrium 
[ ][ ]
[ ][ ] [ ]znz
z
n NaK
Mel)Na(HS
NaMelHSK +
+
Τ =⋅=                                                  (5) 
KΤ is the binding constant at 1 M Na+ concentration and is usually described as Knonionic, as 
ionic interactions are much reduced at this concentration. On the other hand, K is the actual 
binding constant derived directly from the ITC experiment which varies with the Na+ 
concentration (table 3). Taking the logarithm on both sides of equation (5) and rearranging 
gives 
log K = log KT - z log [Na+]                                        (6) 
A plot of the experimental log K as a function of log [Na+] should be linear with slope z 
and y-intercept log KT. Figure 3 shows this linear relation for the melittin/HS system. 
Linear regression analysis yields +Naz = -2.26 (about two Na
+ ions are released when 
melittin binds to HS) and the nonionic binding constant KT = 1.4 × 103 M-1. 
 
Figure 3 
 
The variation of the thermodynamic parameters with salt concentration is displayed in 
Figure 4. The reaction enthalpy 0melittinHΔ  is independent of NaCl concentration, but 
0
melittinSΔ  decreases with increasing ionic strength. This indicates that the salt dependence 
of 0melittinGΔ  is entropic in origin. This was also observed for the binding of oligolysines to 
duplex DNA (33) and singles-stranded polynucleotides (34, 35) and for the binding of 
tripeptide containing lysine to heparin (36). 
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Figure 4 
 
Structural properties of melittin binding to HS. Structural changes of synthetic melittin 
induced by binding to HS were followed by circular dichroism (CD) spectroscopy. The  
 
Figure 5 
 
CD spectra of melittin in buffer (10 mM Tris, 100 mM NaF, pH 7.4, room temperature) 
were measured at a peptide concentration of 44 μM and were titrated with a 22 μM solution 
of HS.  
The corresponding CD spectra are displayed in Figure 5. For better visualization they are 
separated into three regions of low (A), middle (B), and high (C) HS content. Figure 5 
demonstrates that melittin adopts an essentially random coil (rc) conformation in the 
absence of HS. The random coil content is 60% but α-helix and β-structure contribute 22% 
and 19%, respectively. Upon addition of HS the α-helix content increases steeply to about 
56% at a HS-to-melittin ratio of ~0.12, whereas further addition of HS induces a slow 
increase to 63% α-helix at a HS-to-melittin ratio of 0.5. The conformational change 
involves several structural transitions and cannot be described by a 2-state equilibrium over 
the full range. However, at low HS-to-melittin ratios (0-0.02) a 2-state equilibrium is 
observed with isosbestic points at λ ~ 195 and 228 nm (5A). For high HS-to-melittin ratios 
(0.06 ≤ r ≤ 0.1) a second 2-state transition region appears with an isosbestic point at λ ~ 
208 nm (5C). The conformational changes in the intermediate region 0.04 > r > 0.1 are 
characterized by a steep increase and decrease of β-turn structure (cf. 5B). Analogous CD 
titrations of melittin were performed with dermatan sulfate and heparin. The corresponding 
CD spectra are qualitatively and quantitatively very similar to those obtained for HS. 
Chapter 3 48 
Helix formation in aqueous solution is an exothermic process with a reaction enthalpy of 
0
helixHΔ  ~ -0.9 to -1.1 kcal/mol (37, 38). The increase in α-helix content of melittin by 
41%, corresponding to 10.7 amino acid residues, should thus entail a reaction enthalpy of 
about -10 kcal/mol. In addition, the electrostatic interaction of the 3 Lys and 2 Arg side 
chains with the HS sulfate groups could also make an exothermic contribution. However, 
the experimental result 0melHΔ  ~ -1.5 kcal/mol is far different from this theoretical 
expectation. As an explanation it may be speculated that the helix-coil transition in the 
melittin-HS system has an enthalpy close to zero or that the enthalpy is even slightly 
positive. The classical example for a positive ΔHhelix is the coil-to-helix transition of 
poly(γ-benzy-L-glutamate) (PBGL) with 0helixHΔ  = +890 cal/mol per residue (39), taking 
place in ethylene dichloride/dichloroacetic acid (DCA). The random coil conformation is 
stabilized by specific PBGL-DCA interactions which are broken up at higher temperatures. 
In analogy, it can be argued that binding of melittin to HS requires removal of water 
molecules from melittin and/or HS, which is an endothermic process. The release of water 
would make a positive contribution to the entropy. We have measured CD spectra of 
melittin bound to HS as a function of temperature in the range 5-40°C. We observe a 15% 
reduction in the mean residual ellipticity while the shape of the spectra remains unchanged. 
As the CD-spectrum of a perfect helix is itself sensitive to temperature (37), the observed 
change is consistent with the literature data and excludes a melting of the helix. This 
measurement also supports the conclusion the enthalpy of the coilVhelix transition of the 
melittin-HS system is close to zero. It may further be noted that 0helixHΔ  was found to 
decrease in mixed H2O/trifluoroethanol (TFE) solvents (37) assuming a value 0helixHΔ = -
0.1 kcal/mol residue in pure TFE.  
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DISCUSSION 
We observe a strong binding of melittin to three different GAGs, but no binding of nisin Z 
or magainin 2. Nisin Z has lysine residues at positions 12, 22 and 34. The cationic charges 
are spaced far apart and they cannot act in concert. For magainin 2 with lysines at positions 
4, 10, 11 and 14 the electric charge density is higher but the spatial distances appear not to 
agree with the stereochemistry of the sulfated sugars. Melittin on the other hand, has a 
cluster of 4 cationic charges at amino acids. 21-24 followed by 2 glutamines at 25-26 
which could make additional H-bridges. The significance of the spatial arrangement of the 
lysine and arginine residues is supported by a related study of synthetic peptides interacting 
with the heparin binding domain of the heparin/heparan sulfate interacting protein. The all-
L-amino acid peptide and the all-D-amino acid version of the same peptide had the same 
efficacy as agents for neutralization of the anticoagulant activity of heparin. In contrast, a 
peptide with a scrambled peptide sequence had no effect. The spatial pattern of the charged 
amino acids was found to be of critical significance (40).  
 
Structural Model. The HS employed in the present binding studies is composed of about 29 
disaccharide units, based on an average molecular weight of 13'655 Da for HS and 464 Da 
for a sulfated disaccharide unit. On the other hand, a sulfur content of 5.51% leads to 23.5  
−
4SO  groups. As each disaccharide unit also carries a -COO
- group the total anionic charge 
of HS is about zHS = -53 ± 5. Charge neutralization is achieved if 10-11 melittin molecules 
are bound, provided each melittin contributes 5 positive charges. This is only possible if 
melittin with its helical axis is extended parallel to the HS chain as 4 cationic amino acids 
are clustered at the C-terminus whereas the 5th (Lys-7) is located at the other end of the 
molecule. Figure 6 shows a schematic representation to approximate scale of a complex 
consisting of 
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Figure 6 
 
HS (29 disaccharide units) and 11 melittin molecules in helical conformation. In a 3-
dimensional picture the melittin molecules should be wrapped around the disaccharide 
string producing hydrophobic interactions between neighboring melittins. The HS itself 
may also adopt a curled conformation. Inspection of the crystal structure of melittin (41) 
reveals a distance of 9.22 Å (10.05 Å) between the +NH3 groups of Lys 21 - Arg 24 (Arg 
22 - Lys 23). The distance between 2 sulfate groups on heparin has been estimated as 8 - 
8.6 Å ((42); fig. 1D). As there is no perfect match of distances, both melittin and HS must 
rearrange their structure to produce optimum ion pair formation.  
The binding stoichiometry of melittin (n = 11) is distinctly smaller than those of the 
analogs [Cys1] melittin (n = 15.5 ± 0.7) and retro-inverso [Cys1] melittin (14 ± 1.5) 
investigated previously (24). The replacement of the N-terminal glycine of melittin by 
cystein in the analogs appears to modify the binding properties such that only the cationic -
KRKR- carboxy terminus but not K-7 in the hydrophobic N-terminal region bind to HS. A 
larger number of ligands compared to natural melittin is hence required to guarantee 
electroneutrality of the HS-melittin-analog complexes. The increased ligand density 
requires a different packing model for the two melittin analogs. While the charged N-
terminus is associated with the HS chain, part of the C-terminus must extend away from 
the chain axis into the aqueous phase.  
 
Thermodynamic and structural aspects of melittin binding to HS. Melittin has a high 
affinity to HS as shown by the calorimetric data presented here. The binding constant at 28 
˚C is K = 2.4 x 105 M-1, corresponding to a dissociation constant of 4.2 μM.  
At low temperatures (≤ 15°C) the melittin-HS interaction is endothermic and binding is 
exclusively driven by entropic forces. Above 15°C the reaction enthalpy changes to 
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exothermic but even at 50°C the entropy term accounts for 35% of the total free energy 
ΔG0. The large negative heat capacity change of 0 melittin,pC  = -227 cal/mol suggests 
hydrophobic interactions as the source of the entropy gain. The binding affinity of natural 
melittin is somewhat smaller than those of its analogs [Cys1]melittin (6.5 x 105 M-1) and 
retro-inverso [Cys1]melittin (4.0 x 105 M-1) (24). 
Coulombic interactions between the cationic peptide and the anionic HS make an essential 
contribution to the free energy of binding. The Mel-HS binding constant decreases with 
increasing salt concentration to K = 1.3 × 103 M-1(extrapolated) at 1 M NaCl. Compared to 
K = 3 × 105 M-1 at 100 mM NaCl this corresponds to a reduction of 43% in the free energy 
ΔG. The change in ΔG0 is essentially entropic in nature as the reaction enthalpy ΔH0 is 
virtually independent of the salt concentration.  
Melittin binding to HS may be compared with the interaction of a basic cyclic peptide to 
heparin for which an extensive ITC study was performed (43). The brain natriuretic peptide 
(BNP) has a cyclic structure which is related to an acidic fibroblast growth factor. BNP 
contains 32 amino acids with 3 Lys and 4 Arg and is comparable in size and charge to 
melittin. The binding constant to heparin is K = 2 × 105 M-1 (100 mM NaCl, 50 mM −4PO , 
25°C, pH 7.4) which is very similar to melittin binding to HS (3 × 105 M-1). On the other 
hand, heparin carries more sulfate groups than HS and the BNP-heparin interaction 
normalized to the charge density is thus weaker than the melittin-HS interaction. The 
reaction enthalpy is in the range of -3.2 kcal/mol ≤ ΔHBNP ≤ -0.4 kcal/mol depending on the 
salt concentration. The molar heat capacity is ΔCp = 1 kcal mol-1 K-1 (referred to heparin) 
and thus opposite in sign to that of the melittin-HS reaction (ΔCp,melittin = -227 cal mol-1 K-
1). The positive heat capacity suggest strong polar interactions. This is, however, 
contradicted by the rather small salt dependence of the BNP-heparin binding constant. The 
ionic contribution was estimated as only 6% which is much lower than that found for 
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melittin-HS or other heparin-binding proteins (44-48). Only 0.5 Na+ ions are replaced upon 
BNP binding.  
BNP binding to heparin is accompanied by a distinct protonation reaction. 5 H+ are bound 
upon complex formation (43). We have therefore investigated the buffer dependence of the 
melittin-HS reaction. The reaction enthalpy varies only slightly between -1.5 kcal/mol 
(TRIS) over -1.8 kcal/mol (phosphate) to -2.6 kcal/mol (MOPS, HEPES), but is not 
correlated with the buffer dissociation enthalpies. A proton uptake or release can thus be 
excluded. The binding constant in phosphate buffer is only 1.1 × 105 M-1(50 mM −4PO , 100 
mM NaCl) which can be explained by a specific interaction between melittin and −4PO  
(49).  
In elucidating the cytolytic action mechanism of melittin most researchers have focused on 
the interaction of melittin with the lipid part of the cell membrane and only a few reports 
have discussed the role of glycosaminoglycans. It was suggested, for example, that melittin 
forms a complex with heparin secreted from mast cells neutralizing, in turn, the cytotoxic 
effect of melittin (50). Complexes between melittin and heparin result in an enhanced 
immune response to the peptide present in the complex (51). Melittin-induced cell lysis has 
been described in some detail for red blood cells (2), human lymphoblastoid cells (52, 53) 
or Caco-2 cells (54). However, the molecular mechanism of cell lysis was not addressed in 
these studies.  
The present data suggest that the melittin-GAG interaction should be investigated as a 
potential target initiating cell lysis enhancing, perhaps, the melittin-lipid interaction. As a 
first step in this direction we have investigated the effect of melittin on two related Chinese 
hamster ovary (CHO) cell lines, one of which has a reduced content of sulfated GAGs. We 
have used the pgsA-745 mutant cell line (ATCC, Manassas, VA) which is deficient in 
xylosyltransferase, the enzyme responsible for the initiation of chondroitin sulfate and 
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heparan sulfate biosynthesis in vivo (55). As a control we used CHO K1 cells (ATCC, 
Manassas, VA). After incubation with melittin the cell viability was determined with 
CytoTox-OneTM Homogeneous Membrane Integrity Assay (Promega Corporation, 
Madison, WI) according to the manufacturer’s instruction. Differences in the cytotoxic 
effect of melittin for these two cell lines were observed in the range of peptide 
concentrations 3 to 5 μM. At 3 μM melittin the percent cytotoxicity is 44.8 ± 4.3 % for 
CHO K1 cells but only 31.6 ± 2 % for pgsA-745 cells with reduced GAG content. Even 
though the main mechanism is probably the permeabilization of the lipid membrane these 
data suggest that the role of GAGs cannot be ignored. A more detailed report including 
results from different cell lines and confocal microscopy is in preparation. 
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TABLES 
 
Table 1 – Titration of synthetic melittin with HS. Thermodynamic parameters as a function 
of temperature in buffer (10 mM Tris 100 mM NaCl at pH 7.4.) 
 
 
T 
(˚C) 
 
 
n 
 
K 
(M-1) 
 
0
melittinHΔ  
(kcal/mol) 
 
0
melittinGΔ  
(kcal/mol) 
 
0
melittinSTΔ  
(kcal/mol) 
 
0
molSΔ  
(cal/molK) 
 
5 
 
11.2 
 
1.9 x 105 
 
4.60 
 
-6.71 
 
11.31 
 
40.7 
 
10 
 
13.5 
 
2.0 x 105 
 
2.80 
 
-6.86 
 
9.66 
 
34.1 
 
15 
 
12.5 
 
2.2 x 105 
 
2.30 
 
-7.04 
 
9.34 
 
32.4 
 
28 
 
11.0 
 
2.4 x 105 
 
-1.50 
 
-7.41 
 
5.91 
 
19.6 
 
37 
 
10.4 
 
2.3 x 105 
 
-2.20 
 
-7.60 
 
5.40 
 
17.4 
 
50 
 
 
9.5 
 
2.0 x 105 
 
-6.10 
 
-7.83 
 
1.73 
 
5.4 
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Table 2 – Thermodynamic parameters for synthetic melittin binding to heparin and DS. 
Buffer: 10 mM Tris 100 mM NaCl, pH 7.4. 
 
 
T 
(˚C) 
 
 
n 
 
K 
(M-1) 
 
0
melittinHΔ  
(kcal/mol) 
 
0
melittinGΔ  
(kcal/mol) 
 
0
melittinSTΔ  
(kcal/mol) 
 
Heparin 
 
 
 
 
 
 
 
 
 
5 
 
2.6 
 
0.9 x 106 
 
5.40 
 
-7.57 
 
12.97 
 
10 
 
2.6 
 
1.0 x 106 
 
3.50 
 
-7.77 
 
11.27 
 
37 
 
2.7 
 
0.9 x 106 
 
-3.90 
 
-8.45 
 
4.55 
 
Dermatan Sulfate 
 
 
 
 
 
 
 
 
 
10 
 
30.5 
 
1.1 x 106 
 
3.90 
 
-7.82 
 
11.72 
 
28 
 
40.0 
 
1.2 x 106 
 
-0.90 
 
-8.37 
 
7.47 
 
37 
 
 
38.0 
 
1.0 x 106 
 
-2.50 
 
-8.51 
 
6.01 
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Table 3 – The effect of NaCl on the thermodynamic parameters of HS binding to bee 
venom melittin at 28 ˚C. Buffer: 10 mM Tris and variable concentrations of NaCl at pH 
7.4. 
 
 
NaCl 
(mM) 
 
 
n 
 
 
K 
(M-1) 
 
0
melittinHΔ  
(kcal/mol) 
 
0
melittinGΔ  
(kcal/mol) 
 
0
melittinSTΔ  
(kcal/mol) 
 
50 
 
9.8 
9.5 
 
1.0 x 106 
1.0 x 106 
 
-1.40 
-1.50 
 
-8.26 
-8.26 
 
6.86 
6.76 
 
100 a)  
 
8.5 
10.0 
 
3.0 x 105 
3.5 x 105 
 
-1.70 
-1.20 
 
-7.54 
-7.64 
 
5.84 
6.44 
 
150 
 
10.0 
10.0 
 
1.0 x 105 
1.0 x 105 
 
-1.50 
-1.50 
 
-6.89 
-6.89 
 
5.39 
5.39 
 
250 
 
 
10.0 
10.0 
 
 
2.5 x 104 
3.0 x 104 
 
-1.40 
-1.30 
 
-6.06 
-6.17 
 
4.66 
4.87 
 
a) The small differences to the data in table 1 can be explained by the different source of 
melittin which is melittin from natural source in table 3 but synthetic melittin in table 1.  
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LEGENDS 
FIGURE 1. Titration of HS into synthetic melittin. (A) Calorimetric trace obtained at 28 °C 
by titration of HS (100 μM) into a solution of melittin (91 μM). Each peak corresponds to 
the injection of 10 μL of HS into the calorimeter cell. (B) Heats of reaction (integrated 
from the calorimetric trace) plotted as a function of the HS/melittin ratio. The solid line is 
the best fit to the experimental data (■) using the binding model described by eqs 1-3 with 
the following parameters: 0melittinHΔ = -1.50 kcal/mol, K = 2.4 x 105 M-1, n = 11. Buffer: 10 
mM Tris, 100 mM NaCl, pH 7.4. 
 
FIGURE 2. Temperature dependence of the thermodynamic parameters. (A) 0melittinHΔ  for 
synthetic melittin binding to HS. Linear regression analysis of the experimental data in 
yields  0melittinHΔ  = 5.47 – 0.227T (°C) (solid line). (B) Binding constant K0. The solid line 
in (B) is the predicted temperature dependence of K0 based on the van’t Hoff equation and 
using the above regression formula for 0melittinHΔ (T). Buffer: 10 mM Tris, 100 mM NaCl, 
pH 7.4. 
 
FIGURE 3. Salt dependence of the interaction between HS and bee venom melittin. 
Binding constant (K0) for HS binding to melittin was determined as a function of NaCl 
concentration in Tris buffer (10 mM Tris, pH 7.4) from ITC measurements at 28 °C. K 
values are plotted as a function of the NaCl concentration on log/log scale. Linear 
regression analysis of the experimental data yields log K = 3.14 – 2.26 log [NaCl] (solid 
line). 
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FIGURE 4. Dependence of 0melittinGΔ , 0melittinHΔ , and 0melittinSTΔ  on the NaCl concentration in 
Tris buffer (10 mM Tris, pH 7.4) at 28 °C for the interaction of bee venom melittin with 
HS. 
 
FIGURE 5. CD spectra monitoring conformational changes in bee venom melittin upon 
addition of heparan sulfate. Mean residue ellipticity values of melittin (44.3 μM) in the 
absence and upon titration with heparan sulfate (22 μM) are plotted as a function of the 
wavelength. (A) black – melittin; red – HS/melittin 0.01; green – HS/melittin 0.02; (B) 
blue – HS/melittin 0.04; cyan – HS/melittin 0.06; magenta – HS/melittin 0.08; orange – 
HS/melittin 0.10; (C) dark grey – HS/melittin 0.12; violet – HS/melittin 0.16; pink – 
HS/melittin 0.20; yellow – HS/melittin 0.30; dark yellow – HS/melittin 0.50. Buffer: 10 
mM Tris, 100 mM NaF, pH 7.4. 
 
FIGURE 6. Schematic representation of melittin-HS interactions. HS with 29 disaccharide 
units ( ), total length ~290 Å. Melittin helix (  ) length ~37 Å, diameter ~11 Å.  
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APPENDIX – LIGHT SCATTERING MEASUREMENTS 
Static light scattering studies. A turbid solution is observed when melittin is mixed with 
HS and the association reaction can conveniently be followed by light scattering. The 
measurements were performed in a Jasco FP 777 spectrofluorimeter (Japan-Spectroscopic, 
Tokyo, Japan). Typically, 2.8 mL solution of melittin (53 μM) was titrated with HS (200 
μM) at 5 min intervals, under constant stirring at room temperature. The scattering 
intensity at 365 nm (with the excitation wavelength set to 350 nm) was measured and 
recorded as a function of time. 
 
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
0
1000
2000
3000
4000
5000  HS-into-buffer
 HS-into-melitin
In
te
ns
ity
, a
.u
.
HS/melittin molar ratio
 
Figure 1. Right-angle static light scattering obtained by titration of HS into bee venom melittin. (●) Each data 
point corresponds to the injection of 15 μL of HS (200 μM) into a solution of melittin (53 μM). (○) Control 
titration, where HS is injected into pure buffer. Buffer: 10 mM Tris, 100mM NaCl, pH 7.4. 
 
 
Figure 1 shows the scattering intensity when small aliquots of HS solution (200 μM) where 
titrated into melittin (53 μM) (●) or into pure buffer (○). The scattering intensity of melittin 
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solution increases upon addition of HS, reaching the maximum at a HS/melittin molar ratio 
of ~ 0.16, which corresponds to a peptide/HS ratio of 6.3. Beyond this point a decrease in 
scattering intensity was observed, indicating that some of the larger aggregates/complexes 
were dissolved in the presence of excess HS. 
 
Dynamic light-scattering studies. To determine the size of the complexes/aggregates which 
are formed upon titration of melittin with HS and to confirm results obtained in static light 
scattering studies, we have applied dynamic light scattering. Dynamic light scattering 
measurements were performed in Zetasizer Nano ZS (Malvern Instruments Ltd., 
Worcestershire, UK). Typically, 0.6 mL solution of melittin (65.7 μM) was titrated with 
small aliquots of HS (200 μM). 
Figure 2A shows the correlation function for aggregates/complexes formed at HS-to-
melittin molar ratio of 0.20. The rate of decay for the correlation function is related to a 
particle size and it is much slower for large particles than it is for small ones. After the 
correlation function was measured, the software of the instrument provides the decay rates 
and calculates the size distribution. A typical size distribution graph is shown in Figure 2B. 
It is the relative intensity of the scattered light as a function of size. In Figure 2B size 
distribution shows one single peak with average diameter of particles of 171.3 nm. 
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Figure 2. (A) Correlation function and (B) size distribution graph for aggregates/complexes at HS-to-melittin 
molar ratio of 0.20. Buffer: 10 mM Tris 100 mM NaCl at pH 7.4. 
 
 
The intensity distribution was converted using Mie theory to volume distribution by 
software provided with the instrument. The volume distribution was then used in further 
analysis. Figure 3 shows the size distribution by volume of melittin upon titration with HS.  
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Figure 3. Size distribution by volume for titration of melttin solution (65.7 μM) with HS (200 μM) 
determined by dynamic light scattering. Buffer: 10mM Tris 100 mM NaCl at pH 7.4. 
 
 
For melittin in the absence of HS two populations of different size particles are found 
(Figure 3A). One population of the particles has the size of 3.8 nm, corresponding 
approximately corresponds to the length of the peptide molecules. The size of the second 
population is determined as 66.6 nm, suggesting the presences of the peptide aggregates. 
To compare results obtained for different HS-to-melittin molar ratios the z-average size 
(also known as the “cumulants mean”), a mean value for the size, is used. However when 
the polydispersity index (PDI) is larger than 0.5, it is not advised to rely on the z-average 
A 
B 
C 
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size, but rather a distribution analysis should be used to determine the peak position. PDI of 
0.723 was found at HS-to melittin molar ratio of 0.05. The plot of the size distribution 
shows a single peak with maximum at ~ 1148 nm at a HS-to-melittin molar ratio of 0.05 
(Figure 3A). These results indicate presence of very big and heterogeneous 
aggregates/complexes. At higher molar ratios of HS-to-melittin the PDI decreases below 
0.5. At a HS-to-melittin ratio of 0.10 (PDI of 0.236) the peak position at 959.4 nm (Figure 
3B) and the z-average size of 921.1 nm are found. Further addition of HS moves the peak 
position towards smaller particles (Figure 3B and 3C) and a significant decrease in the z-
average size is observed (Figure 4), indicating that big aggregates/complexes are dissolved 
again. The z-average size of 171.3 nm (PDI of 0.024), 180 nm (PDI of 0.197), and 87.35 
nm (PDI of 0.047) are found at HS-to-melittin molar ratios of 0.20, 0.30, and 0.50 
respectively. 
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Figure 4. The z-average size of melittin-HS aggregates/complexes determined by Dynamic Light Scattering 
plotted as a function of HS/melittin molar ratio. For melittin in the absence of HS the particles size of 3.8 nm 
is taken. For HS/melittin molar ratio of 0.05 the distribution analysis of the peak position to determine the 
size of the particles was used, since PDIs was found to be 0.723. 
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The maximum sizes of the particles are found at HS to melittin molar ratios of 0.05 and 
0.10, what correspond to peptide/HS molar ratio of 20 and 10, respectively. This result 
corresponds better to stoichiometry found by ITC than the result obtained by static light 
scattering method. 
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4. CYTOTOXICITY OF MELITTIN ON CELLS 
INTRODUCTION 
In addition to its powerful antimicrobial and lytic activity melittin exhibits a variety of 
other biological effects such as inhibition and aggregation of membrane proteins (1-4), 
inhibition (H+ + K+) ATPase (5) and (Na+ + K+) ATPase (6), increasing cell membranes 
permeability to ions and stimulating activity of phospholipase A2 (7). Although extensive 
studies on the interaction between melittin and cell membranes or lipids have been 
performed, the molecular origin of the cytolytic activity of melittin is not fully established.  
It was shown that melittin has a higher affinity to membranes composed of negatively 
charged lipids than for zwitterionic lipids, indicating that electrostatic interactions are 
involved in the binding of melittin to membranes (8, 9). The membrane of the eukaryotic 
cells contains only about 10% anionic lipids which are mainly localized in the inner leaflet 
of the healthy cell membrane. The outer membrane of eukaryotic cells contains 
predominantly neutral lipids such as phoshaptidylcholine (10). However, almost all cell 
surfaces are decorated with sulfate carrying glycosaminoglycans (GAGs). It was shown 
that GAGs have been implicated in the internalization of several CPPs, including the full 
TAT protein and oligoarginine (11, 12). Also many pathogenic microorganisms use cell 
surface GAGs as receptors for attachment and invasion. Adherence and penetration of 
herpes simplex virus (HSV) depends on cell surface heparan sulfate (13, 14). In Chlamydia 
trachomatis, heparan sulfate acts as bridge, binding both host cell receptors and Ch. 
trachomatis (15, 16). In the present study we have shown that melittin has a high affinity to 
heparan sulfate (HS) with a microscopic binding constant of ~ 105 M-1 at temperatures 
from 5 to 50 °C. Two other antimicrobial, but non-lytic peptides, magainin 2 and nisin Z do 
not bind to HS. These results suggest that GAGs could be involved in the mode of action of 
melittin on the eukaryotic cells. In order to study in vivo involvement of GAGs in the 
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binding of melittin to cell membranes, cell lines deficient in GAGs would be the most 
suitable. Mutants of Chinese hamster ovary cells (CHO) lacking GAGs have been reported 
(17). Some lines lack both heparan and chondroitin sulfate. Other strains produce heparan 
sulfate or chondroitin sulfate only. Some cell lines are defective in polymer modifications 
reactions, such as GlcNAc deacetylation/N sulfation or IdUA 2-O sulfation (17-20).  
In this study we have used the pgsA-745 mutant cell line, which is deficient in 
xylosyltransferase, the enzyme responsible for the initiation of chondroitin sulfate and 
heparan sulfate biosynthesis in vivo. These mutant cells do not produce GAGs (17). 
Cell viability can be defined based on the integrity of the cell membrane. One of the 
methods to estimate the number of non-viable cells is to measure the leakage of 
cytoplasmic components into the surrounding culture medium, when the membrane 
integrity is lost. A particularly useful cytoplasmic metabolite released upon cell death is 
lactate dehydrogenase (LDH). By estimating the amount of LDH in the culture medium, it 
is possible to estimate the number of non-viable cells and, in turn, the influence of external 
agents on the cell metabolism. To determine the cytotoxic effect of melittin on different 
cell lines, we have used the CytoTox-ONE™ Homogenous Membrane Integrity Assay 
(Promega Corporation, Madison,WI, USA). This assay reveals the release of LDH from 
cells with damaged membranes. Release of LDH from damaged cells is measured by 
supplying lactate, NAD+, resazurin as substrates in the presence of diaphorase. Generation 
of the fluorescent resorufin product is proportional to the amount of LDH. The scheme is 
shown in Figure 1. 
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Figure 1. Release of LDH from damaged cells is measured by supplying lactate, NAD+, and resazurin as 
substrates in the presence of diaphorase. Generation of the fluorescent resorufin product is proportional to the 
amount of LDH (adapted from CytoTox-ONE™ Technical Bulletin, Promega Corporation, Madison, WI). 
 
 
MATERIALS AND METHODS 
Materials. Synthetic melittin was purchased from Bachem (Bubendorf BL, Switzerland) 
(purity >97% by reverse phase HPLC). The peptide was used without further purification. 
The concentration of melittin stock solution in Hepes buffer (20 mM Hepes, 118 mM 
NaCl, 5 mM KCl, 1.3 mM CaCl2, 0.5 mM MgCl2) was determined by UV spectroscopy at 
280 nm using absorption coefficient of 5570 M-1cm-1. Serial dilution of melittin stock 
solution were prepared in Dulbecco’s modified Eagle’s medium (DMEM) with 2 mM L-
Glutamine, 4500 mg/L D-Glucose, without sodium pyruvate, supplemented with 7% (v/v) 
fetal bovine serum. All cell culture media and supplements were from Gibco-BRL (Basel, 
Switzerland). 
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Cell Lines. Chinese hamster ovary cell line CHO K1 (ATCC, Manassas, VA, USA) and 
pgsA-745 cells (ATCC, Manassas, VA, USA), a mutant deficient in xylosyltransferase 
were kindly provided by Prof. Ballmer (Paul Scherrer Institut, Villingen, Switzerland). 
Both cell lines were grown in F12-K medium with 2 mM L-Glutamine, 100 U/mL 
penicillin, 100 μg/mL streptomycin and 10% (v/v) fetal bovine serum.  
Both cell lines were grown at 37 °C in a humidified atmosphere with 5% CO2. 
 
Cytotoxicity assay. CHO K1, pgsA-745 cells (10,000 cells per well in 96-well plates) were 
seeded in growth medium for 24 h and cultured at 37 °C and 5% CO2. Melittin stock 
solution in Hepes buffer was diluted in Dulbecco’s modified Eagle’s medium (DMEM) 
with 2 mM L-Glutamine, 4500 mg/L D-Glucose, 7% fetal bovine serum , without sodium 
pyruvate (GIBCO) and added to the cells. Then the cells were incubated for 30 min at 37 
°C and 5% CO2. After incubation time, the cell viability was determined with CytoTox-
One™ Homogenous Membrane Integrity Assay (Promega Corporation, Madison, WI, 
USA) according to the manufacturer’s instructions. Briefly, after the incubation with 
peptide the assay plate was removed from 37 °C incubator and equilibrated 5 min at room 
temperature. 100 μL of CytoTox-ONE™ Reagent was added to 100 μL of medium 
containing cells. Plate was shaked for 30 s and incubated at RT for 10 min. After 
incubation time 50 μL of Stop Solution was added to each well to rapidly stop the 
continued generation of fluorescent product. Plate was shaked for 10 s and fluorescence 
with λex = 560 nm and λem = 590 nm was recorded. 
In parallel, control measurements were performed. No-cell control was used to determine 
the background fluorescence. A control of untreated cells served as a vehicle control. A 
maximum LDH release control allowed to determine the maximum LDH release. To 
generate maximum LDH release, Lysis solution [9% (w/v) solution of Triton X-100] was 
used. 
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The average fluorescence values from experimental, maximum LDH release and culture 
medium background were used to calculate the percent of cytotoxicity for a given 
experimental treatment in the following way: 
 
 
)Background Medium Culture - Release H(MaximumLD
)Background Medium Culture - tal(Experimen ty cytotoxici ofpercent  =  
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RESULTS 
The cytotoxic effect of melittin on the integrity of the plasma membrane of CHO K1 and 
pgsA-745 is shown in Figure 2. 
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Figure 2. Cytotoxic effect of melittin on the CHO K1 and pgsA-745 cells was measured using LDH release 
assay after incubation with various concentration of melittin for 30 min at 37 °C and 5% CO2. Data are 
expressed as the mean of three independent experiments ± SE. 
 
 
At low concentrations up to 1 μM of melittin we did not observe any effect of the peptide 
on both cell lines, the percent of cytotoxicity is in the same range of about 8 to 9% as for 
untreated cell control. At high concentration of 10 μM effect of melittin is almost the same 
as the maximum LDH release. The percent of cytotoxicity is 98.5 ± 0.9% for CHO K1 and 
96.4 ± 2.1% for pgsA-745 cells. These results indicate that all cells are lysed. The 
differences in the cytotoxic effect of melittin for these two cells lines are observed in the 
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range of peptide concentration of 3 to 5 μM. The value of the percent of cytotoxicity is 
higher for CHO K1 cells than for pgsA-745 at the same concentration. At 3 μM of melittin 
the percent of cytotoxicity are 44.8 ± 4.3% for CHO K1 cells and 31.6 ± 2.0% for pgsA-
745 cells. At higher concentration of the peptide of 5 μM, the percent of cytotoxicity is 
69.5 ± 4.4% and 60.3 ± 1.5% for CHO K1 and pgsA-745, respectively. IC50 (the dose 
required to kill 50% of a tested population) values were then extrapolated from graphical 
plots of cytotoxicity curves. For CHO K1 cell line the IC50 was determined to be 3.4 ± 0.3 
μM. For pgsA-745 cells deficient in GAGs the value of IC50 is higher and is 4.3 ± 0.1 μM. 
 
 
DISCUSSION 
Melittin belongs to the family of antimicrobial peptides and kills various bacteria already in 
micromolar range of concentrations. The inhibitory concentration, IC90, for the 
antimicrobial activity for melittin towards Escherichia Coli and Micrococcus Luteus were 
5.7 μM and 8.8 μM, respectively (21). In the other study minimal inhibitory concentration 
towards E. Coli, Bacillus subtilis and Staphylococcus areus are found to be 3.9 μM, 2.0 μM 
and 3.6 μM, respectively (22). These values are comparable to the concentration required 
to induce lysis of the eukaryotic cells. Weston and Raison examined the cytolytic effect of 
melittin on a human lymphoblastoid cell line (HMy2) and found that the toxicity of 
melittin was linear over the concentration range 0.875-3.5 μM (23). Tosteson showed that 
already 0.6 μM of melittin induce lysis of 70% of erythrocytes. In another study lower 
hemolysis was showed. It was observed that 10 μg/mL (3.5 μM) of melittin induce lysis of 
60% of the red blood cells (24). In case of other antimicrobial peptides such as magainin 2 
and nisin A, concentrations required to induce hemolysis are much higher. A lack of 
hemolysis for magainin 2 was demonstrated up to 150 μg/mL, what corresponds to 60.8 
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μM (25). In the recent study Maher and McClean showed minimal hemolysis of magainin 
2 even up to 400 μg/mL (162.14 μM) (21). They also observed that 1000-fold greater 
concentration of nisin A than the antimicrobial IC90 value (18.7 μM towards E. Coli) lysed 
only 12% of sheep erythrocytes. Cell viability can be determined, not only with the LDH 
release assay, but also with MTT assay and neutral red uptake assay. MTT assay is based 
on the reduction of the tetrazolium salt, methylthiazolyldiphenyl (MTT) into blue formazan 
product by oxidoreductases of viable cell. The resultant formazan formation is proportional 
to the number of viable cells. The neutral red uptake assay is based on the neutral red 
(toluylene red) dye, which is actively transported into lysosome of viable cells. The cellular 
uptake of the dye is proportional to the number of viable cells. The IC50 values for melittin 
determined with MTT assay for HT29 and Caco-2 cells are 1.2 μM and 1.8 μM, 
respectively, whereas the IC50 determined in the same assay for magainin 2 were 81 μM for 
HT29 cells and 79.9 μM for Caco-2 cells. In the assay based on neutral red dye uptake, the 
IC50 values for melittin were 5.6 μM for HT29 cells and 4.7 μM for Caco-2 cells. In the 
case of magainin 2 for both cell lines concentrations of up to 100 μM were employed 
without reaching the IC50 value (21). 
The IC50 value, determined with LDH release assay, for melittin-induced lysis in control 
cell line, CHO K1, is 3.4 μM. The IC50 value for melittin-induced lysis in cell line which 
lacks GAGs is found to be 4.3 μM. Surprisingly the IC50 for the mutant cell line is only 1.3 
higher than this one obtained for the wild type cells.  
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Table 1. The p values determined by student’s t-test for each concentration of melittin tested and IC50 from 
three independent experiments.  
 
0.5 μM 
 
 
1.0 μM 
 
3.0 μM 
 
5.0 μM 
 
10.0 μM 
 
IC50 
 
0.152 
 
 
0.268 
 
0.024 
 
0.059 
 
0.201 
 
0.032 
 
 
Only at 3 μM concentration of melittin and IC50, the p values are less than 0.05, but higher 
than 0.01, which is considered as a borderline statistically significant. The level of 
significance, p ≤ 0.05, still involves high probability of error (5%).  
If the GAGs are involved in the lytic mechanism of action of melittin, it was hoped that the 
differences in the toxic effect of the peptide on the two cell lines discussed above would be 
much more pronounced. However the surface of eukaryotic cells is not only decorated with 
sulfated GAGs, but also with other charged glycolipids and glycoproteins. For instance, 
gangliosides; contain negatively charged sialic acid residues, which contribute to the 
negative charge of the cell surface. More detailed studies on the interaction of melittin and 
other microbial peptides with glycolipids and glycoproteins are required to better 
understand the mechanism of melittin-induced toxicity. 
It is also known that the lysis of eukaryotic cells is a fast process and that most cells die 
within 30 min (23). Observations under the light microscope showed that the red blood 
cells were lysed within two minutes after exposure to melittin (26). If there are any 
differences in the mode of action of melittin between wild type cells and mutant cells 
deficient in GAGs, these should only be observed in the very short time after addition of 
the peptide to the cells. Unfortunately, the assay used in our studies does not have a 
sufficiently short time resolution and it was not possible to follow the early stages of the 
melittin-cell membranes interaction. The fluorescence-activated cell sorting (FACS) 
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analysis seems to be appropriate for such an approach. This technique allows rapid 
analyses of large populations of cells using the appropriate fluorescence signal. Using this 
method it should be possible to record the cytotoxicity of melittin within minutes after 
addition of the peptide to the cells. 
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5. BINDING OF RiDOM TO SULFATED CELL SURFACE SUGARS 
INTRODUCTION 
Melittin posseses membrane disturbing properties and the net positive charge and therefore 
it can be an interesting candidate for gene delivery. Melittin binds to DNA by charge 
interaction, but the melittin/DNA complex does not mediate transfection. Instead it induces 
toxicity, due to fast partitioning of the peptide into cell membrane (1-3). To overcome the 
problem of toxicity and in order to increase the stability of the DNA-melittin complex and 
transfection efficiency, additional effectors can be used. A hybrid molecule, obtained by 
covalent coupling of an amphiphatic, membrane disturbing peptide to lipid moiety, can 
create a stable and efficient gene transfer system. Dioleyolmelittin (DOM) is such a hybrid 
molecule resulting from the conjugation of dioleoylphosphatidylethanolamine-N-[3-(2-
pyridyldithio)propionate] with [Cys1]melittin, an analog of melittin in which the N-
terminus glycine was replaced by cysteine. It was shown that DOM can form homogenous 
small particles with DNA and it mediates efficient transfection of various cell lines. 
Successful transfections have been reported for cells CV-1 (monkey kidney fibroblasts), 
CHO K1 (Chinese hamster ovary cells) and HEK 293 (human embryonic kidney cells) (4). 
But it was also shown that DOM is toxic and not stable. Retro-inverso dioleyolmelittin 
(riDOM), the structure of which is shown in Figure 1, is another hybrid molecule, in which 
the lipid is coupled to retro-inverso analog of [Cys1]melittin, where all L-amino acids 
residues are replaced by the corresponding D-isomers and the amino acid sequence of the 
peptide is reversed. RiDOM shows no hemolytic activity, is much less toxic in transfection 
than DOM, and it is stable over months. 
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Figure 1. Structure of riDOM (retro-inverso dioleoylmelittin). 
 
 
The net positive charge of melittin conjugates suggest that similarly to other cationic lipids 
and cell-penetrating peptides, the cellular uptake of these molecules is mediated by GAGs. 
We have also already shown that melittin interacts strongly with sulfated cell surface 
sugars; therefore we have decided to study thermodynamic equilibrium of the riDOM/HS 
interactions.  
 
 
MATERIALS AND METHODS 
Materials. RiDOM was kindly provided by Dr. Eric Kitas from F. Hoffman-La Roche Ltd 
(Basel, Switzerland). Heparan sulfate (HS) sodium salt (from porcine intestinal mucosa, 
average molecular weight, 13 655 Da, sulfur content 5.51%) and dermatan sulfate (DS) 
sodium salt (from porcine intestinal mucosa, average molecular weight, 41 400 Da, sulfur 
content 6.85%) were from Celsus Laboratories (Cincinnati, OH). Low molecular weight 
heparin sodium salt (from porcine intestinal mucosa, average molecular weight 3000) was 
from SIGMA (St. Louis, MO, USA).  
All other chemicals were of analytical or reagent grade. Tris buffer (10 mM 
tris(hydroxymethyl)aminoethane, pH 7.4) was prepared from 18 MΩ water obtained from a 
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NANOpure A filtration system. NaCl concentrations were variable (50 to 250 mM) and are 
specified in the legends of each figure. The samples were degassed immediately before use. 
 
Isothermal Titration Calorimetry. All measurements were made with a MicroCal VP-ITC 
calorimeter (MicroCal, Northampton, MA, USA). Titrations were performed by injecting 
5-10 μL aliquots of the glycosaminoglycan solution into the calorimeter cell (Vcell = 1.4037 
mL) containing riDOM at a concentration of typically 100-200 μM. The concentrations of 
the injected glycosaminoglycan solution were about 50 μM for HS, 21 μM for DS and 490 
μM for heparin.  
The heats of dilution were determined in control titrations by injecting a 
glycosaminoglycan or lipid solution into pure buffer. The heats of dilution were small (~ -1 
to 1 μcal), and were included in the final analysis. Raw data were processed using Origin 
software provided with the instrument. The temperature was set as indicated in the legends 
of the figures. All measurements were performed in Tris buffer (10 mM, pH 7.4) with 
varying NaCl concentrations. 
 
Binding model. For a complete thermodynamic characterization of the binding process, the 
calorimetric data were analyzed with a multisite binding model, which was also used to 
describe the binding equilibrium of other peptides to HS (5, 6). In this model a long 
polymer such as HS is described as a macromolecule with n independent and equivalent 
binding sites for a ligand like melittin. The binding model is represented by the following 
equation: 
 
]P[K1
]P[nK
]HS[
]P[
t
b
+=                                                                                                                  (1) 
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[P] and [P]b are the concentrations of free and bound melittin, respectively, [HS]t is the 
total concentration of HS, K is the intrinsic binding constant, n is the number of melittin 
Because of mass conservation, the concentration of bound peptide can be described by: 
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The index t denotes the total concentration of peptide and HS in the calorimeter cell after 
each injection step. The peptide concentration changes during the titration with HS because 
of dilution effects. 
The concentration of bound peptide is linked to the calorimetric data by the following 
equation: 
 
V]P[HQ i,b
0
riDOMi δΔ=δ                                                                                                         (3) 
 
where δQi is the heat absorbed or released in injection ith, 0riDOMHΔ  is the peptide binding 
ethalpy, δ[P]b,i is the change (increase) in bound peptide concentration upon injection i, and 
V is the volume of the calorimeter cell (7). 
 
Circular Dichroism Spectroscopy. CD measurements of riDOM in the absence and the 
presence of glycosaminoglycan (buffer 10 mM Tris, 100 mM NaF, pH 7.4) were made 
using a Chirascan CD spectrometer (Applied Photophysics Ltd. Leatherhead, UK). A 
quartz cuvette with a path length of 0.1 cm was used. All spectra were corrected by 
substracting the buffer baseline. Results are reported as mean residue ellipticity in units of 
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deg cm2 dmol-1. The percentage of peptide secondary structure was estimated from a 
computer simulation based on the reference spectra obtained by Reed and Reed (8) 
 
Dynamic Light Scattering. Dynamic light scattering measurements were performed in 
Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, UK). Typically, 1.3 mL 
solution of riDOM (50 μM) was titrated with HS (150 μM). The results of the volume 
distribution are shown. 
 
 
RESULTS 
Binding of riDOM to HS. Figure 2 shows a calorimetric heat flow trace (Figure 2A) and the 
corresponding titration curve (Figure 2B) obtained at 5 °C by titration of riDOM (100 μM) 
with 5 μL aliquots of HS (50 μM). The integrated heats in Figure 2B represent the net heats 
of each injection after correcting for the heats of dilution of the HS obtained in separate 
HS-into-buffer titration. 
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Figure 2. Titration of HS into riDOM. (A) Calorimetric trace obtained at 5 °C by titration of HS (50 μM) into 
a solution of riDOM (100 μM). Each peak corresponds to the injection of 5 μL into the calorimeter cell. (B) 
Heats of reaction (integrated from the calorimetric trace) plotted as a function of the HS/riDOM ratio. The 
solid line is the best fit to the experimental data (■) using the binding model described by eqs 1-3 with the 
following parameters: 0riDOMHΔ  = 0.85 kcal/mol, K = 2.5 x105 M-1, n = 23. Buffer: 10mM Tris, 10mM NaCl, 
pH 7.4. 
 
 
Figure 2 demonstrates an endothermic reaction at 5 °C. The heats measured during the few 
injections are relatively constant with hi ≈ 4.52 μcal per injection. The theoretical curve 
(solid line calculated using the binding model of eqs 1-3 with n = 23, K = 2.5 x 105 M-1, 
and 0riDOMHΔ = 0.85 kcal/mol) indicates that after five injections ~ 20% of the total riDOM 
in the calorimeter cell is bound to HS. At this point, an additional endothermic reaction 
takes place, which extends between ~ 20% and ~ 89% of bound riDOM. The additional 
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heat, referenced to the total amount of riDOM, is HΔ ~ 0.46 kcal/mol, which is ~ 54% of 
the total reaction heat. The molecular nature of this second reaction is unclear. A similar 
behavior has been observed for the titration of one of the analogs of melittin, 
[Cys]1melittin, with HS (9). It was also reported for the titration of DNA with multivalent 
cations, and was interpreted in terms of DNA condensation and aggregation (10). The 
second additional reaction in the riDOM-HS interaction could correspond to a 
reorganization of the complex to more compact aggregate.  
Calorimetric titrations were performed at different temperatures in the range of 5-50 °C. 
Table 1 summarizes the thermodynamic parameters obtained by using the binding model 
described by eqs 1-3. 
 
Table 1. Titration of riDOM with HS. Thermodynamic parameters as a function of temperature in buffer (10 
mM Tris, 10 mM NaCl at pH 7.4) 
 
T 
(˚C) 
 
 
n 
 
K 
(M-1) 
 
0
riDOMHΔ  
(kcal/mol) 
 
0
riDOMGΔ  
(kcal/mol) 
 
0
riDOMSTΔ  
(kcal/mol) 
 
5 
 
23.0 
24.0 
 
2.5 x 105 
2.6 x 105 
 
0.85 
0.77 
 
-6.87 
-6.91 
 
7.72 
7.68 
 
15 
 
23.0 
 
3.1 x 105 
 
0.65 
 
-7.24 
 
7.89 
 
25 
 
18.0 
20.0 
 
3.5 x 105 
3.5 x 105 
 
0.65 
0.65 
 
-7.56 
-7.56 
 
8.21 
8.21 
 
37 
 
20.0 
 
4.0 x 105 
 
0.40 
 
-7.95 
 
8.35 
 
50 
 
 
20.0 
 
4.0 x 105 
 
0.20 
 
-8.28 
 
8.48 
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The binding stoichiometry of riDOM/HS varies between 18 and 24. 0riDOMHΔ  is positive at 
all temperatures tested, decreasing from ~ 0.85 kcal/mol to ~ 0.20 kcal/mol as the 
temperature is raised from 5 to 50 °C. From the slope of the straight line in Figure 3A, we 
obtained a very small negative molar heat capacity change of 0 riDOM,pCΔ  = -13 cal mol-1 K-1. 
The solid line in Figure 3B describes the predicted temperature dependence of the binding 
constant K based on the van’t Hoff law dlnK/dT = 0riDOMHΔ  / RT2 taking into account the 
temperature dependence of the reaction enthalpy as HΔ (T) = 0HΔ  + 0pCΔ (T – T0). 
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Figure 3. Temperature dependence of the thermodynamic parameters. (A) 0riDOMHΔ , for riDOM binding to 
HS. Linear regression analysis of the experimental data yields 0riDOMHΔ  = 0.88 – 0.013T (°C) (solid line).  
(B) Binding constant K0. The solid line in (B) is predicted temperature dependence of K0 based on the van’t 
Hoff equation and using the above regression formula for 0riDOMHΔ (T). Buffer: 10mM Tris, 10mM NaCl, pH 
7.4. 
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We have also studied interaction of riDOM with heparin and DS. ITC titration curves 
exhibits the same pattern as those observed for HS at the identical temperatures (Figure 4).  
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Figure 4. Titration of HS, heparin, DS into riDOM. (A) Calorimetric trace obtained at 25 ˚C by titration of 
HS (100μM), heparin (490μM), DS (21μM) into a solution of riDOM (112-200 μM). Each peak corresponds 
to the injection of 8 μL of HS and 5 μL of heparin and DS into the calorimeter cell. (B) Heats of reaction 
(integrated from the calorimetric trace) plotted as a function of the HS/heparin/DS to melittin ratio. The solid 
line is the best fit to the experimental data (■) using the binding model described by eqs 1-3 with the 
following parameters: for (i) HS-into-riDOM: 0riDOMHΔ  = 0.65 kcal/mol, K = 5.0 x 105 M-1, n = 18; (ii) 
heparin-into-riDOM: 0riDOMHΔ  = 0.4 kcal/mol, K = 5.0 x 105 M-1, n = 3; (iii) DS-into-riDOM: 0riDOMHΔ  = 
0.53 kcal/mol, K = 1.0 x 106 M-1, n = 95. Buffer: 10mM Tris, 10mM NaCl, pH 7.4. 
 
 
For DS the binding constant, K, is larger than those obtained for HS and heparin at 25 °C. 
For DS the binding constant is of order 106 M-1. The riDOM molar binding enthalpies, 
0
riDOMHΔ  at 25 °C are 0.4 kcal/mol for heparin and 0.53 kcal/mol for DS. The main 
difference found between these glycosaminoglycans is the binding stoichiometry. The 
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number of binding sites for riDOM at 25 °C is 3 for heparin, 18 for HS, and 95 for DS. 
Since the three polysaccharides have a different molecular weight, a better comparison is 
the binding capacity per 1 kDa which is ~ 1 for heparin, ~ 1.3 for HS, and ~ 2.3 for DS.  
 
Salt effect on binding of riDOM to HS. We have also performed titrations of riDOM with 
HS at different salt concentrations. 
The ITC titrations patterns were identical to those observed for titrations done at low salt 
concentrations (10 mM NaCl), but the total heat released during the titrations was lower. 
At 25 °C the total enthalpy of the reaction determined from the total heat released in the 
titration (~ 109.6 μcal) and the amount of the riDOM in the calorimeter cell (280.7 nmol) is 
0.39 kcal/mol, whereas for the same experiment performed at 10 mM NaCl in buffer, the 
enthalpy derived from the total heat released in the titrations (~ 280.3 μcal) and the amount 
of riDOM (~280.7 nmol) is 1.0 kcal/mol. 
The calorimetric data were then analyzed with the binding model described by Eqs 1-3. 
The thermodynamic parameters obtained at 25 °C are summarized in Table 2. 
 
Table 2. The effect of NaCl on the thermodynamic parameters of HS binding to riDOM at 25 °C. Buffer: 10 
mM Tris and variable concentrations of NaCl at pH 7.4. * Mean ± SD of three measurement. 
 
NaCl 
(mM) 
 
 
n 
 
 
K 
(M-1) 
 
0
riDOMHΔ  
(kcal/mol) 
 
0
riDOMGΔ  
(kcal/mol) 
 
0
riDOMSTΔ  
(kcal/mol) 
 
10 
 
18 
20 
 
3.5 x 105 
3.5 x 105 
 
0.65 
0.65 
 
-7.56 
-7.56 
 
8.21 
8.21 
 
50 
 
18.0 
 
3.0 x 105 
 
0.30 
 
-7.47 
 
7.77 
 
100* 
 
25.3 ± 6.0 
 
(2.6 ± 0.7) x  105 
 
0.20 ± 0.02 
 
-7.37 ± 0.17 
 
7.57 ± 0.19 
 
150 
 
 
23.0 
 
2.0 x 105 
 
0.08 
 
-7.23 
 
7.31 
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The binding affinity of HS to riDOM decreases with increasing salt concentration in the 
buffer. Therefore we can analyze the salt dependence of the binding constant with a model 
for protein-polyelectrolyte interactions (11). 
HS is a highly charged poly-anion but a considerable fraction of its sulfate groups is 
probably neutralized by Na+ due to counterion condensation (12). Upon binding of riDOM 
the counterions are released into the bulk solution as described by the following reaction 
scheme: 
 
HS(Na)z + n riDOM ↔ HS · riDOMn + zNa+                                                                      (4) 
 
with the corresponding equilibrium 
 
z
n
z
z
n
T ]Na[K]riDOM][)Na(HS[
]Na][riDOM.HS[K +
+
=⋅=                                                                             (5) 
 
KT is the binding constant at 1 M Na+ concentration and is usually described as Knonionic, as 
ionic interactions are much reduced at this concentration. On the other hand, K is the actual 
binding constant derived directly from the ITC experiment which varies with Na+ 
concentration (Table 2). Taking the logarithm on both sides of the equation (5) and 
rearranging gives  
 
[ ]+−= NalogzKlogKlog T                                                                                               (6) 
 
A plot of the experimental log K as a function of log [Na+] shows linear dependency in the 
riDOM/HS system (Figure 5). Linear regression analysis yields log K = 5.1 – 0.3 log 
[NaCl]. The y-intercept is the nonionic binding constant at 1 M Na+ of 1.26 x 105 M-1. 
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Figure 5. Salt dependence of the interaction between riDOM and HS. Binding constant (K0) for HS binding to 
riDOM was determined as a function of NaCl concentration in Tris buffer (10 mM Tris, pH 7.4) from ITC 
measurements at 25 °C. K values are plotted as a function of the NaCl concentration on log/log scale. Linear 
regression analyis of the experimental data yields log K = 5.1 – 0.3 log[NaCl] (solid line). 
 
 
The variation of the thermodynamic parameters with changing salt concentration is 
displayed in Figure 6. The thermodynamic parameters of riDOM, 0riDOMHΔ , 0riDOMGΔ , and 
0
riDOMSΔ , are dependent on the NaCl concentration. Enthalpy and entropy of the binding 
reaction, 0riDOMHΔ  and 0riDOMSΔ  (Figure 6A, B), decrease with increasing ionic strength.  
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Figure 6. Dependence of (A) 0riDOMHΔ , (B) 0riDOMSTΔ , and (C) 0riDOMGΔ  on the NaCl concentration in Tris 
buffer (10mM Tris, pH 7.4) at 25 °C for the interaction of riDOM with HS. 
 
 
Structural properties of riDOM binding to HS. To check structural changes in riDOM 
induced by interaction with HS, we have analyzed the secondary structure of riDOM in the 
absence and presence of HS with CD spectroscopy. The CD spectra were obtained at 25 °C 
in 10 mM Tris, 10 mM NaF and pH 7.4. RiDOM at concentration of 50 μM was titrated 
with 150 μM solution of HS. The CD spectrum of riDOM is mirror-imaged at the x-axis 
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compared to the conventional α-helix spectrum because riDOM is composed of all D-amino 
acids (Figure 7).  
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Figure 7. CD spectra monitoring confromational changes in riDOM upon addition of HS. Mean residue 
ellipticity values of riDOM (50 μM) in the absence and upon titration with HS (150 μM) are plotted as a 
function of wavelength. (A) black – riDOM; red – HS/riDOM 0.02; green – HS/riDOM 0.06; (B) blue – 
HS/riDOM 0.08; magenta – HS/riDOM 0.10; yellow – HS/riDOM 0.15; orange – HS/riDOM 0.20. Buffer: 
10 mM Tris, 10mM NaF, pH 7.4. 
 
 
Figure 8 shows calculated content of α-helix, β-structure and random coil (RC) of riDOM 
upon addition of HS. In the absence of HS α-helix and RC contribute almost equally to the 
secondary structure of riDOM. The content of α-helix and RC is ~ 35.1% and ~ 34.6%, 
respectively. The β-structure content is not much lower and is ~30.3%. Upon titration with 
HS the α-helix content decreases to 11.3% at 0.06 HS-to-riDOM molar ratio, and then 
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increases slowly again up to 31.1% with further addition of HS. The β-structure content 
increases to the highest value of ~70% at 0.06 HS-to-riDOM molar ratio. Further addition 
of HS causes slow decrease of β-structure. At HS/riDOM molar ratio of 0.2 the β-structure 
content is ~42.2%. The RC content first decreases to 18.8% at HS-to-riDOM molar ratio of 
0.06, and then increases to ~26.4% at HS-to-riDOM molar ratio of 0.2. 
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Figure 8. Calculated content of α-helix (black bars), β-structure (grey bars) and RC (white bars) of riDOM 
upon titration with HS. Buffer: 10 mM Tris, 10 mM NaF, pH 7.4. 
 
 
Dynamic light scattering studies. A turbid solution is observed when riDOM is mixed with 
HS. Formation of complexes/aggregates and determination of their size can be followed 
with Dynamic Light Scattering. Figure 9 shows the size distribution by volume of when the 
HS solution (150 μM) is titrated into riDOM (50 μM).  
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Figure 9. Size distribution by volume for titration of riDOM solution (50 μM) with HS (150 μM) determined 
by dynamic light scattering. Buffer: 10mM Tris 10 mM NaF at pH 7.4 
 
 
For riDOM in the absence of HS the very high PDI of 0.842 is found. The particle size of 
10.10 nm is determined from the peak position. Addition of HS causes an increase in size 
and increase in the number of populations of different size aggregates/complexes. Already 
at low HS-to-riDOM molar ratio of 0.02 two population of particles are observed. Their 
size determined from the peak position is about 63 nm and 212 nm and the volume they 
occupied is 80% and 20%, respectively. The PDI of 0.258 and the z-average size of 115 nm 
are found. At 0.04 HS-to-riDOM molar ratio three populations of particles with different 
A 
B 
C 
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size are observed. The largest fraction (60%) are particles with size of 126 nm. Two 
additional fractions are about equal in size and contribute particles with 306 nm and 1311 
nm. Further addition of HS does not dramatically change the situation in the system. We 
still observe presence of two populations of different size aggregates/complexes. The size 
of one group changes from about 150 nm at 0.08 HS-to-riDOM molar ratio to 174 nm at 
0.16 HS-to-riDOM molar ratio. The size of the second population varies from about 490 
nm at 0.04 HS-to-riDOM molar ratio to 1362 nm at 0.16 HS-to-riDOM molar ratio. At 0.20 
HS-to-riDOM molar ratio part of the large aggregates is dissolved and a third population is 
observed with size of about 534 nm. The PDI for all presented molar ratios (except riDOM 
in the absence of HS) is below 0.5, so the results can be compared by the z-average size. 
Figure 9 shows z-average size as a function of HS-to-riDOM molar ratio. At the beginning 
of titration the z-average size increase steeply to value of about 182 nm at 0.04 HS-to-
riDOM molar ratio. Further addition of HS causes at first a slow increase to maximum z-
average size of 238 nm at 0.16 HS-to-riDOM and then a decrease to 222 nm at 0.20 HS-to-
riDOM molar ratio. 
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Figure 10. The z-average size of riDOM-HS aggregates/complexes determined by Dynamic Light Scattering 
plotted as function of HS/riDOM molar ratio. For riDOM in the absence of HS the distribution analysis of the 
peak position to determine size of particles was used, since PDI was found to be 0.842. 
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DISCUSSION 
The calorimetric data show that riDOM has a high affinity to heparan sulfate (HS). The 
binding constant at 50 mM NaCl and 25 °C is K = 3.5 x 105 M-1, corresponding to a 
dissociation constant of 2.9 μM. This result is similar to binding data obtained for melittin 
and melittin analogs: at 50 mM NaCl binding constants of K = 1.0 x 106 M-1, 6.5 x 105 M-1 
and 6.3 x 105 M-1 were found for melittin, ri-mel-SH and mel-SH, respectively (9).  
RiDOM binds rapidly and tightly to two other glycosaminoglycans, heparin and dermatan 
sulphate. ITC titration curves and thermodynamic parameters are similar to those of HS 
indicating that the binding process occurs in the same way as for the interaction of riDOM 
with HS. 
For riDOM the reaction enthalpies are positive and unfavourable for binding in the range 
of temperature tested (5-50 °C) and the binding of riDOM to HS is entropy driven. Again 
similar to mel-SH and ri-mel-SH. 
The essential element of the binding process is the electrostatic interaction between the 
cationic riDOM and the anionic groups of HS. The binding constant decreases upon 
increasing the ionic strength of the buffer. The contribution of electrostatics in the binding 
process can be estimated from the extrapolated binding constant at 1M NaCl from Figure 5, 
which shows a linear relation between the observed binding constant of HS to riDOM and 
the NaCl concentration in double logarithmic plot. The slope of the regressed line in Figure 
5 gives the number of Na+ ions released in the association reaction, whereas the y-intercept 
at 1 M NaCl provides an estimate of the non-ionic binding constant with 1.3 x 105 M-1. 
When compared to the binding constant measured at 25 °C and 10 mM NaCl, this value 
suggests contribution of electrostatics to the free energy of binding ~10%. This is 
confirmed by the salt dependence of the binding equilibrium. The increase of NaCl content 
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results in decrease of the binding heats. The reaction enthalpy, 0riDOMHΔ , at 10 mM NaCl is 
0.65 kcal/mol, whereas at 100 mM NaCl the reaction enthalpy is found to be 3 times lower. 
Enthalpies close to zero and large positive entropy values are typical of hydrophobic 
interactions (13). The temperature dependence of the reaction enthalpy reveals the negative 
value of the molar heat capacity change indicating hydrophobic component in the binding 
process of riDOM with HS. The negative values of heat capacity change were also 
observed for the interaction of melittin and melittin analogous with HS (9). The 
hydrophobic interactions are also observed for the binding of cationic lipids to DNA (14, 
15). The hydrophobic contribution to the binding process could arise from the interaction 
between solvent and solvent exposed hydrophobic lipid part of the molecule, aggregation 
of the riDOM-HS complexes or self association of the riDOM molecules. The binding of 
riDOM to HS cause formation of bigger complexes/aggregates. Initially, addition of HS to 
riDOM results in dramatic increase in the mean size of the particles to about 180 nm at 
HS/riDOM molar ratio of 0.04. At this molar ratio the end of the aggregation process at the 
calorimetric trace is observed. Indeed, further additions of HS to riDOM cause only slight 
increase of the mean size of the particles to about 200-220 nm. Formation of homogenous 
particles with the diameter of about 200 nm was also observed for DOM-DNA complexes 
(4). 
In summary, the overall interaction of riDOM with HS comprises both ionic and 
hydrophobic components. Ionic contributions result from the interaction of the cationic 
moiety of riDOM with the negatively charged sulfate groups of the HS chain. Hydrophobic 
interaction arises from the interaction between hydrocarbon groups of the lipid moiety, 
aggregation of the formed complexes and conformational changes upon binding of riDOM 
with HS.  
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6. INTERACTION OF MELITTIN WITH LIPIDS 
INTRODUCTION 
Melittin, the main component of bee venom from Apis melifera, is short cationic peptide 
composed mainly of hydrophobic amino acid residues at the amino terminus (positions 1-
20) and hydrophilic amino acid residues at the carboxy terminus (positions 21-26) (1).This 
uneven distribution of hydrophilic and polar residues gives melittin amphiphilic properties. 
Melittin, unstructured in water, adopts an α-helical conformation upon binding to lipids 
membranes (2). Melittin-lipid membrane interactions have been studied extensively and it 
was shown that they depend on the lipid composition, the peptide concentration, the 
hydration level and the membrane potential (3-7). For instance the binding of melittin to 
membranes composed of negatively charged lipids is stronger compared to neutral 
membranes (4, 8). Different mechanisms have been proposed for the activity of melittin. In 
one model, melittin insert into the hydrophobic core of the membrane and forms either 
barrel-stave (9, 10) or toroidal (7, 11) pores. In the other model, ‘detergent-like’, melittin 
due to a cluster of cationic residues at carboxy terminus and a stretch of hydrophobic 
residues behaves much as a detergent (12). Positively charged melittin binds onto the 
surface of the membrane. At low concentrations of the peptide, molecules are oriented 
parallel to the surface of the bilayer. An increase of the peptide concentration causes 
further aggregation and reduction of bilayer thickness. When the threshold concentration is 
reached, the peptide changes its orientation and disrupts the bilyer curvature inducing 
destabilization and disintegration of the membrane (12-15). 
There are many studies, which have used many different biophysical techniques, but so far 
no thermodynamic equilibrium using titration calorimetry was described. We used high-
sensitivity isothermal titration calorimetry (ITC) to study the thermodynamic equilibrium 
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between melittin and electrically neutral large unilamellar vesicles composed of 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC). 
 
 
MATERIALS AND METHODS 
Materials. Melittin was purchased from BACHEM AG (Bubendorf BL, Switzerland) 
(purity > 97% by reverse phase HPLC). The concentration of melittin in aqueous solution 
was determined by UV spectroscopy at 280 nm using an absorption coefficient of 5570 M-
1cm-1 (16). POPC was obtained from Avanti Polar Lipids Inc. (Alabaster, AL, USA). 
All other chemicals were of analytical or reagent grade. Tris buffer (25 mM 
tris(hydroxymethyl)aminoethane, pH 7.4) was prepared from 18 MΩ water obtained from a 
NANOpure A filtration system. NaCl concentrations were variable (50 and 100 mM) and 
are specified in the legends of each figure. The samples were degassed immediately before 
use. 
 
Preparation of lipid vesicles. A defined amount of POPC was dried from a stock solution 
in chloroform under a gentle stream of nitrogen followed by high vacuum overnight. The 
lipids were resuspended in buffer (25 mM Tris, 50 mM or 100 mM NaCl at pH 7.4) with 
gentle vortex mixing leading to multilamellar vesicles (MLVs) with a final lipid 
concentration of 20-25 mM. Large unilamellar vesicles (LUVs) vere prepared by extrusion 
of MLV suspensions using extruder. After five consecutive freeze-thaw cycles, MLVs 
were extruded 12 times through polycarbonate membrane with pore diameter of 100 nm 
(Whatman, Clifton, NJ). 
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Isothermal Titration Calorimetry. All measurements were made with a MicroCal VP-ITC 
calorimeter (MicroCal, Northampton, MA, USA). Titrations were performed by injecting 
10 μL aliquots of POPC (25 mM) at constant time interval (10 min) into the calorimeter 
cell (Vcell = 1.4037 mL) containing peptide at a concentration of typically 8-16 μM.  
The heats of dilution were determined in control titrations by injecting a lipid solution into 
pure buffer and were included in the final analysis. Raw data were processed using Origin 
software provided with the instrument. The temperature was set as indicated in the legends 
of the figures.  
 
 
RESULTS 
The interaction of melittin with uncharged lipid vesicles was studied with by ITC. 
Following the protocol for lipid-into-peptide titrations (17), a diluted solution of melittin 
(8-16 μM) in buffer was filled in the calorimeter cell (Vcell = 1.4037 mL) and small aliquots 
(10 μL) of vesicle suspension (20-25 mM total lipid) were injected at defined time intervals 
into the peptide solution.  
Figure 1A shows a representative calorimetric heat flow trace obtained at 60 °C by titration 
of melittin with POPC large unilamellar vesicles (LUVs). The corresponding titration 
curve is shown in Figure 1B, where the reaction heats are plotted as a function of the 
injection number. The reaction heats were obtained by integration of the titrations peaks 
shown in Figure 1A and were corrected for the heats of dilution obtained in a separate 
lipid-into-buffer titration.  
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Figure 1. Titration of POPC into melittin. (A) Calorimetric trace obtained at 60 °C by titration of POPC LUV 
suspension (22 mM) into a solution of melittin (14.5 μM). Each peak corresponds to the injection of 10 μL of 
lipid suspension into the calorimeter cell. (B) Heats of reaction (integrated from the calorimetric trace) plotted 
as a function of injection number. The heat of dilution was measured in a separate control experiment and 
was included in the final analysis. The solid line is the best fit to the experimental data (■) using the surface 
partition equilibrium model. Buffer: 25mM Tris and 50 mM NaCl at pH 7.4. 
 
 
Figure 1 demonstrates an exothermic reaction at 60 °C. The heat of reaction decreases with 
increasing number of injections, since less and less peptide is available for binding. When 
all peptide is bound to POPC vesicles, the residual heats of the last injections are due to 
dilution of lipid vesicles into buffer. The molar binding enthalpy of melittin is then 
determined from the total heat released in the titration (~50.9 μcal) and the amount of 
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peptide in the calorimeter cell (20.35 nmol). For the experiment shown in Figure 1 the heat 
of reaction is 0melittinHΔ  ≈ -2.5 kcal/mol.  
To obtain binding isotherm the experimental data should be treated with appropriate 
binding model. For the neutral membranes electrostatic effects must also be taken into 
account as long as the peptide is charged. Upon binding of charged peptide to an initially 
neutral membrane, the surface of the bilayer becomes gradually charged, leading to a 
membrane surface potential. The concentration of the peptide near the membrane surface is 
then different that in the bulk solution. To account for such effects, the binding isotherm 
was then calculated using a surface partition equilibrium model (17-21). In this model the 
extent of peptide adsorption is linearly related to the peptide surface concentration CM (and 
not to the bulk concentration): 
 
Xb = KCM                                                                                                                             (1) 
 
where Xb denotes the molar amount of peptide bound per mole of lipid and K is the 
partition coefficient. 
CM can be calculated using the Boltzmann relation: 
 
CM = Cf exp(-zp Fo φo / RT)                                                                                                  (2) 
 
where zp is the effective charge of the peptide, Fo is the Faraday constant, φo is the 
membrane surface potential, RT is the thermal energy. The membrane surface potential is 
not known, but can be calculated from the degree of binindg, Xb using the Gouy-Chapman 
theory [for reviews, see ref (22, 23)]. 
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The free energy of binding 0GΔ  can be calculated according to  
 
K5.55lnRTG 0 −=Δ                                                                                                            (3) 
 
where the factor 55.5 is the molar concentration of water and corrects for the cratic 
contribution to the binding event (24).  
Finally the entropy of binding 0SΔ  can be calculated using the relation 
 
000 STHG Δ−Δ=Δ                                                                                                              (4) 
 
Calorimetric titrations were performed at various temperatures in the range of 10-60 °C at 
two different salt concentrations (50 mM NaCl and 100 mM NaCl). Table 1 summarizes 
the thermodynamic parameters obtained by using model described above. 
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Table 1. Temperature dependence of the thermodynamic parameters for the binding of melittin to POPC 
LUVs. Buffer: 25 mM Tris and variable concentrations of NaCl at pH 7.4. 
 
T 
(˚C) 
 
 
0
melittinHΔ  
(kcal/mol 
 
K 
(M-1) 
 
0
melittinGΔ  
(kcal/mol) 
 
0
melittinSTΔ  
(kcal/mol) 
 
0
melittinSΔ  
(kcal/mol K) 
 
50 mM NaCl 
 
 
  
 
 
 
 
10 
 
8.1 
 
4.0 x 104 
 
-8.2 
 
16.3 
 
57.6 
 
20 
 
5.9 
 
6.0 x 104 
 
-8.7 
 
14.6 
 
49.8 
 
30 
 
2.5 
 
7.0 x 104 
 
-9.1 
 
11.6 
 
38.2 
 
50 
 
-1.1 
 
9.0 x 104 
 
-9.9 
 
8.8 
 
27.4 
 
60 
 
-2.5 
 
8.0 x 104 
 
-10.1 
 
7.6 
 
22.9 
 
100 mM NaCl 
 
 
  
 
 
 
 
10 
 
9.9 
 
4.0 x 104 
 
-8.2 
 
18.2 
 
64.2 
 
20 
 
4.8 
 
4.5 x 104 
 
-8.6 
 
13.4 
 
45.6 
 
30 
 
1.2 
 
6.0 x 104 
 
-9.0 
 
10.2 
 
33.7 
 
50 
 
-0.7 
 
6.2 x 104 
 
-9.7 
 
9.0 
 
27.7 
 
60 
 
 
-2.2 
 
5.7 x 104 
 
-9.9 
 
7.7 
 
23.0 
 
 
The reaction enthalpy shows strong temperature dependence at both (50 mM and 100 mM 
NaCl) salt concentrations and changes from endothermic below 50 °C to exothermic above 
this temperature. 0melittinHΔ  varies almost linearly between 10 and 60 °C as demonstrated in 
Figure 2A. The slope of the straight lines yields a molar heat capacity change of 0 melittin,pCΔ  
= -213 cal mol-1 K-1 at 50 mM NaCl content in the buffer and 0 melittin,pCΔ  = -221 cal mol-1 
K-1 at 100 mM NaCl content in the buffer The solid line in Figure 2B describes the 
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predicted temperature dependence of the binding constant K based on van’t Hoff’s law 
dlnK/dT = 0melittinHΔ  / RT2.  
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Figure 2. Temperature dependence of the thermodynamic parameters. (A) for melittin binding to POPC 
LUVs in (■) 25 mM Tris 50 mM NaCl and (●) 25 mM Tris 100 mM NaCl at pH 7.4. (B) Binding constant K 
in (■) 25 mM Tris 50 mM NaCl and (●) 25 mM Tris 100 mM NaCl at pH 7.4. The solid lines in B are the 
predicted temperature dependence of K based on the van’t Hoff equation.  
 
 
Table 1 demonstrates that the reaction is completely entropy driven below 50 °C as 0HΔ > 
0. The free energy of binding is fairly constant. A plot of 0HΔ  vs. 0STΔ  yields a straight 
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line in the temperature range tested (Figure 3). The large heat capacity change provides an 
explanation for this enthalpy-entropy compensation phenomenon, that is, the linear 
correlation between 0HΔ  and 0STΔ . The temperature coefficient of 0HΔ  is 0pCΔ , that of 
0STΔ  is close to 00p SC Δ+Δ . As 0pCΔ >> 0SΔ  the two thermodynamic parameters 0HΔ  
and 0STΔ  vary in parallel. 
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Figure 3. Enthalpy-entropy compensation plot for melittin binding to POPC LUVs. ITC measurement were 
performed in (■) 25mM Tris and 50 mM NaCl at pH 7.4; (●) 25 mM Tris 100 mM NaCl at pH 7.4.  
 
 
DISCUSSION 
Almost all chemical and physical processes are associated with absorption or release of 
heat, which can be measured by titration calorimetry. Isothermal Titration Calorimetry 
(ITC) is a very sensitive technique, which allows the simultaneously measurement of the 
Chapter 6 120 
binding constant K0 and the reaction enthalpy 0HΔ . The corresponding free energy 
0GΔ and the reaction entropy 0SΔ  are then obtained via the standard thermodynamic 
relations (17). Melittin is one of the most studied antimicrobial peptides, but so far no 
direct thermodynamic characterization of melittin binding to lipid membranes using ITC 
was reported in the literature. 
The binding of melittin to the neutral lipid membrane is mainly entropy driven as 0HΔ > 0. 
The binding constant is of order 104 M-1 in the temperature range of 10-60 °C at 50 mM 
NaCl as well as at 100 mM NaCl content in the buffer and shows weak temperature 
dependence. Corresponding free energies change modestly from ~ -8 kcal/mol at 10 °C to 
~ -10kcal/mol at 60 °C. Previous studies using NMR spectroscopy and fluorescence 
techniques showed that melittin binds to lipid membranes with a partition coefficient of 
order 103-105 M-1 (4, 6, 25) and the free energy of partitioning of melittin into the POPC 
vesicles has been estimated to be -7 to -8 kcal/mol (2, 6, 25). The binding is driven by 
hydrophobic interactions between non polar amino acid residues of melittin and the 
phospholipid hydrocarbon layer. In case of negatively charged lipids additional 
electrostatic interactions between the negatively charged membrane surface and the 
positively charged amino acid residues are involved.  
There are few other processes associated with melittin binding to lipid membranes. The 
NMR studies showed that the binding of melittin to membranes composed of different 
lipids induces a conformational change of the lipid headgroups (4-6, 26). Other studies 
showed that binding of melittin to lipid membranes induces an α-helix formation and this 
process is tightly coupled to the partitioning of the peptide into lipid membranes (7, 13, 27-
29). The free energy of partitioning of melittin into the membrane is reduced by 0.4 
kcal/mol per residue, when the peptide folds into the α-helix structure (30). Upon binding 
and partitioning of melittin into the lipid membrane, the peptide can also adopt different 
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orientations. The orientation of melittin helices depends on the membrane composition, its 
hydration, the temperature, and the phase state of the lipid (28, 31). An additional 
complication concerning the orientation of the peptide in the membrane is depicted in the 
observation that melittin does not adopt a fully transmembrane orientation in membranes, 
only so called pseudo-transmembrane orientation (32, 33). One of the key parameters 
which determine orientation of melittin in the lipid bilayer is the peptide concentration. At 
low concentrations of the peptide, the melittin molecules are oriented parallel to the surface 
bilayer. When the peptide reaches a critical (threshold) concentration the molecules change 
their orientation into perpendicular to the lipid bilayer and start to produce pores in the 
membrane (34). Also the self association of melittin from monomer to tetramer and the 
opposite reaction of dissociation can contribute to the overall process of binding of melittin 
to the lipid membranes. The enthalpy of 0HΔ = -4.8 kcal/mol of monomer and entropy of 
0SΔ  = 0.05 kcal/(K. mol of monomer) of self-aggregation of melittin from monomer to 
tetramer were determined using fluorescent spectroscopy (16). 
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7. SUMMARY 
The presented work focused on an alternative mechanism of action of melittin on the 
cell membranes. The study using ITC reveals that melittin has a high affinity for several 
glycosaminoglycans (GAGs), i.e. heparan sulfate (HS), dermatan sulfate and heparin. The 
interaction between peptide and GAGs comprised both electrostatic and non-ionic 
components. Circular dichroism (CD) spectroscopy demonstrates that the binding of 
melittin to HS and other GAGs induces a conformational change to a predominantly α-
helical structure. A model of the melittin-HS complex is presented. Furthermore the 
melittin binding was compared with that of magainin 2 and nisin Z to HS. Magainin 2 and 
nisin Z are two amphiphatic and antimicrobial peptides with similar lipid binding 
properties as melittin, but in opposite to melittin they do not cause lysis of the eukaryotic 
cells. ITC demonstrates that magainin 2 and nisin Z do not bind to HS. This result could 
indicate that the interaction with GAGs is unique property of melittin.  
In order to study in vivo involvement of GAGs in the binding of melittin to cell 
membranes, the cytotoxic effect of the peptide on the cells deficient in GAGs and the 
corresponding wild type cell line was investigated. The lactate dehydrogenase (LDH) 
release assay was employed. The differences in the toxic effect of the peptide on both cell 
lines were hoped to be much more pronounced, what would indicate that indeed GAGs are 
involved in the action mechanism of melittin on the cell membranes. The significant 
difference in the cytotoxic effect of melittin was observed only at one peptide 
concentration. However the surface of the eukaryotic cells is not only decorated with 
sulfated GAGs, but also with other negatively charged molecules and it cannot be excluded 
that they are also a potential target for melitin.  
Furthermore the interactions of retro-inverso dioleoylmelittin (riDOM) with HS were 
studied. RiDOM is a hybrid molecule, obtained by covalently coupling of retro-inverso 
7. Summary 127
analog of melittin to a lipid moiety, to form a stable and efficient gene transfer system, 
which shows no haemolytic activity. ITC demonstrates that riDOM has a high affinity to 
HS, and two other GAGs, namely dermatan sulfate and heparin. CD spectroscopy reveals 
no conformational changes of riDOM upon binding to HS. Dynamic light-scattering 
measurements showed formation of bigger aggregates/complexes when riDOM is titrated 
with HS. Both ionic and hydrophobic interactions contribute to the binding of riDOM to 
HS. 
Last part of the thesis described melittin-lipid membrane interaction using ITC. The 
binding equilibrium between melittin and electrically neutral large unilamellar vesicles 
composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) was studied. 
ITC demonstrates that melittin has a high affinity to neutral lipid membranes. 
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